福寿园2024年上半年在服务延展、科技引领、文化创新等领域多点发力 ACN Newswire

福寿园2024年上半年在服务延展、科技引领、文化创新等领域多点发力

香港, 2024年8月24日 - (亚太商讯 via SeaPRwire.com) — 中国领先的殡葬服务提供商--福寿园国际集团有限公司(「福寿园」或「公司」,连同其附属公司,统称「集团」;股份代号:1448.HK)公布截至2024年6月30日止六个月 (「回顾期内」) 之中期业绩。2024年上半年,中国经济整体稳定运行,长期向好。随着中国全面步入小康社会,站在了新的历史起点上,推动民生福祉达到新水准、不断增强人民群众获得感、幸福感、安全感将是中国在民生领域未来发展的主要目标。进入了新时代,人民群众对美好生活的向往从「生」延伸到「死」,提升人民群众身后事的服务质量、实现「逝有所安」已成为殡葬领域重大时代课题,并不断推动中国殡葬行业向纵深发展。回顾期内,为应对经济大环境和客户消费行为的相应变化趋势,集团从市场和产品的双重维度持续关注,在服务延展、科技引领、文化创新等领域多点发力,因「园」施策,着力满足墓园客户多元化、差异化,特别是精神层面的消费需求,持续提升产品和服务的核心竞争力,实现集团长期可持续发展。2024上半年,本集团总收益达人民币1100百万元,公司拥有人应占溢利及全面收入达人民币299百万元。董事会拟向股东派发2024年中期股息每股6.38港仙,符合本集团所承诺的派息政策,以答谢股东一直以来的支持和肯定。回顾期内,集团在公益事业、公共关系、科技创新、品牌发展方面的表现获得社会各界认可,先后获得第十届亚洲微电影艺术节「金海棠奖」、上海市优秀公关案例评选银奖、第十三届公益节「年度教育公益贡献奖」、第八届中国公益年会「年度中国公益企业」等荣誉。特别是在二零二四品牌强国论坛上,福寿园凭借30年来在品牌建设方面的创新成果,经相关部门及媒体推荐,与华为技术、国家电网、腾讯科技、阿里巴巴、抖音等共同入围「二零二四中国创新品牌500强」,福寿园品牌价值获评价人民币139.95亿元,品牌指数高达431.64分,排名第233位。截至目前,集团的业务已进入十九个省、自治区、直辖市的四十余座城市,包括上海、河南、重庆、安徽、山东、辽宁、黑龙江、福建、浙江、江西、江苏、广西、北京、贵州、内蒙古、甘肃、湖北、河北及陕西,其中包括正在运营的位于全国十七个省的主要城市、直辖市和自治区的墓园和殡仪设施。集团在全国其他重要省份、省会城市及空白区域的拓展计画仍在稳步推进中。集团将以审慎和稳健的步伐,坚守对股东负责的态度,筛选合适的目标,整合多元业务资源,以公允合理的对价收购优质资产。向生命科技服务提供者转型 墓园业务领域具有竞争力集团正在从行业领先的殡葬综合服务商转型为生命科技服务提供者,持续致力于落实「3JI」理念(记号做美,记载做厚,纪念做长)在各地、各墓园的应用。本期间内,在「3JI」理念的导引下,我们推出了墓穴产品+服务的新情绪整合产品,致力于为生命提供创新、艺术和更多维度的服务与满足。截至目前,以「3J」理念设计并成功落地的17家墓园园区,艺术美学得到了深刻的表达,从饱含人文关怀态度的设计理念到内外兼修的园区整体构造,从作为修饰性的自然景观到功能性和艺术性共存的碑体形态,对生命的敬畏和对生命美学的追求均得以彰显。此外,通过本期间「3JI」产品的多点运行,市场和客户的体验回馈令我们鼓舞和兴奋,集团相信「3JI」理念下产品和服务的应用将不断强化本集团墓园产品的核心竞争力,触动客户的需求点,助推下半年墓园业务销量的提升。上半年,在国内建筑行业整体下行的大环境下,集团设计板块的全资子公司天泉佳境专注殡葬领域的规划设计,仍保持了较为稳定的经营和发展,经营业绩及新签项目合同额较二零二三年同期均有增长。天泉佳境通过市场公开招标在本期间获得多地殡葬设施的规划设计业务,其设计实力及经营能力在国内仍保持领先地位。同时,在集团内部,天泉佳境积极践行「3JI」理念,为集团各实体公司的「3JI」规划与落地,提供了强有力的保障,进一步增强集团产品在市场上的竞争力。激发业务活力 实现殡仪业新消费需求回顾期内,集团着重在业务结构调整、客户价值创造、礼仪服务转型和科技赋能管理几个方面开展工作。通过以「新场景、新用品、新服务」为主的核心流程改造,实现现代殡仪的「新消费」需求,激发传统殡仪业务的活力,满足市场差异化、多元化的服务需求,引领行业发展。公司充分关注客户心理需求,利用智慧声光系统改造火化场景,将「冥想疗愈」服务引入告别仪式;研发安灵接运仪式及相关文创产品,提升客户对殡仪服务的体验感和获得感。同时,进一步扩大殡仪用品集中研发和集中采购范围,将「文化纸棺」、「文化灵盒」、「随行香囊」等嵌入到仪式中,确保殡仪「新文化」全覆盖。此外,集团持续推进技术含量高,如防腐和古人沐浴等高附加值服务的推广,强化自身的核心竞争力,助推殡仪服务高品质可持续发展。在人口老龄化的社会背景下,生前契约服务正吸引更多希望尽早安排好自己身后事的客户群,亦得到各级政府及长者服务机构的肯定、支援和服务采购。本期间内,累计签订生前契约11,923份合约(2023年同期:9,272份合约),较上年同期增长28.6%。销量的主要增长来自于机构、政府的解决方案的采购以及来源于制定不同目标层次的产品。自主研发环保智慧火化设备 全方位服务客户集团的环保火化机业务集研发设计、自主生产、全面配套及售后服务为一体,生产智慧环保火化设备及尾气净化处理系统。上半年,集团继续优化产品性能,持续收集客户回馈,进一步提高产品品质,降低运维成本。积极维持国内外客户,做好售前技术支持、售后维修保障工作,研发并提供了旧式JS-2火化炉更新改造服务,以使得现有客户可以分享最新的产品升级和能耗节约成果。同时,集团持续对新型拣灰炉、尾气净化系统设备进行资料统计分析验证,不断优化调整,进一步降低火化时长和燃料消耗。此外,亦在建立环保火化设备板块自身的国内外销售体系。集团亦与国内外多家潜在合作方保持密切联系,亦与多家签订了数台火化机、尾气系统和若干辅助设备的销售合作协定。随着新型城镇化进程推进后相应殡葬设施的建设、人口老龄化趋势和遗体火化率提升的加速,相信各地对环保智慧火化设备的需求将大幅增长。福寿园国际集团有限公司董事局主席兼执行董事白晓江先生表示:「福寿园持续秉承「以人为本、文化为根」的理念,正在从行业领先的殡葬综合服务商转型为生命科技服务提供者,从物理世界「福寿园」向精神世界「福寿元」发展。致力于把「记号做美,记载做厚,纪念做长」。」-完-此新闻稿由博达浩华国际财经传讯集团代福寿园国际集团有限公司发布。如有垂询,请联络:冯嘉莉 / 王佩电话:+852 3150 6788电邮:fsy@pordahavas.com Copyright 2024 亚太商讯 via SeaPRwire.com.
More
2nd ASEAN Battery Technology Conference Strengthens Southeast Asia Battery Ecosystem Through New Collaborations and Expansion ACN Newswire

2nd ASEAN Battery Technology Conference Strengthens Southeast Asia Battery Ecosystem Through New Collaborations and Expansion

SINGAPORE, Aug 24, 2024 - (ACN Newswire via SeaPRwire.com) - The 2nd ASEAN Battery Technology Conference (ABTC) returned and strengthened the commitment to develop a close knitted battery development ecosystem among the Southeast Asian countries. Hosted in Singapore this year by the Singapore Battery Consortium at Singapore at the Shangri-La Rasa Sentosa between 21st and 23rd August 2024.The conference is also jointly organised by the alliance of leading battery related associations in the region - the Thailand Energy Storage Technology Association, the National Battery Research Institute, the National Center for Sustainable Transportation Technology, NanoMalaysia, and the Electric Vehicle Association of the Philippines.Dr. Pimpa Limthongkul, Co-Chairman of ABTC and President of the Thailand Energy Storage Technology Association, said, "This year, we are excited to see the expansion of what we have achieved since we last gathered together last year in Bali. Our alliance has grown from three to now six battery associations in Southeast Asia and we will continue to grow in strength. Witnessing the collaborations between the battery associations, private sector and academia is a celebration of how we are moving forward together to drive innovation for a more connected and eco-friendly future in the region.”On the second day of the conference, over 250 participants and the six leading battery associations in Southeast Asia witnessed the signing of three new Memorandums of Understanding or MoUs that will further the development of batteries in the region.From L to R: Prof. Nonglak Meethong (Professor, Khon Kaen University), Mr. Larry Poon (Business Development Manager, INV CORPORATION PTE. LTD.), Dr. Rezal Khairi Bin Ahmad (CEO, NanoMalaysia Berhad), Mr. Bryan Oh (CEO, NEU Battery Materials Pte Ltd) Mr. Freddie Kim (Managing Director, SAMSUNG SDI SOUTHEAST ASIA), Dr. Sing Yang Chiam, Technical Director Singapore Battery Consortium.Three Memorandums of UnderstandingGigafactory Malaysia (GMSB) and NEU Battery Materials (NEU) to Collaborate on Lithium Battery Recycling DevelopmentThe collaboration will focus on developing “Gigafactory” level operations and manufacturing of innovative battery technologies incorporating nanomaterials for mobility and stationary applications. This collaboration is the progression of the Memorandum of Understanding (“Memorandum”) signed in Bali, Indonesia at the 2023 ASEAN Battery and Electric Vehicle Technology Conference (ABEVTC) to promote cross-country collaboration within ASEAN on battery technology.Singapore-based, NEU, who are specialists in LFP battery recycling will ensure a steady supply of recycled battery material, like lithium carbonate and other metals are made available to GMSB’s Hydrogen-Electric-Vehicle-Battery (HEBATT) Centre for performance testing. GMSB is a subsidiary of NanoMalaysia.The testing of the recycled material is to ensure their viability and sustainability within the Malaysia battery ecosystem, which would expand to localised development of a lithium battery recycling ecosystem for the ASEAN region. NEU and GMSB will facilitate this supply and development based on spent battery material being used in an end-to-end ecosystem.This will also pave the way for the exploration of a joint-development programme for improved recycling efficiency between these two companies.Gigafactory Malaysia Sdn Bhd (GMSB) and Khon Khean University (KKU) to Collaborate on Manufacturing of Cells Developed by GMSBGMSB’s and KKU’s collaboration will leverage their joint expertise and resources, with KKU acting as the outsourced manufacturer for batteries developed by GMSB. The collaboration will also provide knowledge sharing in battery testing and certification that will lead to productivity advancements at GMSB's Hydrogen-Electric-Vehicle-Battery (HEBATT) Centre in Malaysia.This Memorandum of Understanding (MoU) is an extension of an agreement signed at the 2023 ASEAN Battery and Electric Vehicle Technology Conference (ABEVTC) in Bali, which involved key organisations from Singapore, Indonesia, Thailand, Malaysia, and the Philippines.Aligned with the ASEAN Battery Network's mission, this MoU aims to strengthen battery technology development within ASEAN.Institute of Materials Research and Engineering (IMRE), Singapore and INV Corporation to collaborate on Joint Research to Develop Hybrid Battery SeparatorsA Research Collaborative Agreement will be signed between the Institute of Materials Research and Engineering in Singapore and INV to develop the next generation hybrid battery separators, which will address the challenges of safety faced by current rechargeable batteries.This collaboration seeks to play on the strengths and IPs in solid state batteries developed in Singapore. INV is headquartered in Singapore and is the largest battery separator film manufacturer in the world. Its production plants are in Sweden and Malaysia.Samsung SDI Southeast Asia ExpansionSamsung SDI, a high-performance battery manufacturer based in South Korea, opened its Regional HQ in Southeast Asia in Singapore on 19 April 2024. Samsung SDI currently has two manufacturing sites in Southeast Asia, located in Malaysia and Vietnam. To enhance customer service, the company has established two sales offices in Vietnam (December 2023) and Singapore (April 2024).Samsung SDI Southeast Asia PTE LTD (SDISEA) also announced that it will open Samsung SDI R&D Singapore (SDIRS) on 1 September 2024, during the 2nd ASEAN Battery Technology Conference (ABTC).Under its vision of making the world greener and more sustainable through innovative technology, Samsung SDI will provide its customers in Southeast Asia with PRiMX (Prime Battery for Maximum Experience) batteries and technologies in pursuit of utmost customer satisfaction.Hosting of the ABTC is rotated among the co-organisers. In 2025, TESTA will host the ABTC in Thailand.For more information on the programme agenda, please visit our official site: https://reg.eventnook.com/event/ABTC2024/homeThe conference's anchor sponsor is Hyundai Motor Group Innovation Center Singapore (HMGICS), with the gala dinner sponsored by INV Corporation Pte Ltd.Gold sponsors include Amphenol Communications Solutions, Quantel Pte Ltd, Infineon Technologies Asia Pacific Pte Ltd, and Gotion Singapore Pte Ltd, while silver sponsors are Concord New Energy Group Limited, Kewell Technology Co.,Ltd., Metrohm Singapore Pte Ltd, TME Systems Pte Ltd.Additional sponsors include Samsung SDI Southeast Asia Pte. Ltd, Siemens Industry Software Pte Ltd, UL Standards & Engagement, and NEWARE Technology Limited. Publicity partners are the EV Association of Singapore, EV Association of Malaysia, and Turn Off Turn On Ventures.Media ContactPRecious Communicationsabtc@preciouscomms.comAbout ASEAN Battery Technology ConferenceASEAN Battery Technology Conference (ABTC) stands out as the premier battery conference in ASEAN, attracting an audience of over 250 participants. We look forward to engaging with a diverse range of participants, including cell manufacturers, pack integrators, and recycling companies. The mission of ABTC is to bring together regional battery expertise, creating unique opportunities within the global battery value chain.The primary objective of ABTC is to foster collaboration among stakeholders in the battery industry. We aim to facilitate insightful discussions covering various topics, such as advanced battery materials, prototyping, cell-to-pack technologies, and recycling strategies.In addition to these focal points, the conference will explore related aspects such as standards, interoperability, and the ongoing evolution of battery safety technology.Organisers of ABTCAbout Singapore Battery ConsortiumSingapore Battery Consortium (SBC) aims to foster strategic R&D partnerships amongst public research performers and industry players in developing and advancing battery technologies. SBC aims to develop and catalyze the local ecosystem in battery-related technologies through this platform. It is hosted at A*STAR and supported by the National Research Foundation Singapore (NRF). Over the past decade, commercial interest in battery development has been on the rise, keeping pace with demand for better battery performance and different performance characteristics for increasingly complex mobility and portable devices. To meet this demand, the Singapore Battery Consortium will bring research outcomes from our laboratories into the market by enabling researchers to understand business requirements, while giving companies access to the latest battery research and technologies to augment their product development efforts.About Thailand Energy Storage Technology Association (TESTA)TESTA or THAILAND ENERGY STORAGE TECHNOLOGY ASSOCIATION aims to help connect stakeholders, educate the public, promote understanding, and nurture technological advancements in energy storage technologies in Thailand. TESTA was officially registered on January 25, 2021, by 5 founding institutes including the National Science and Technology Development Agency (NSTDA), Khon Kaen University (KKU), King Mongkut’s University of Technology Thonburi (KMUTT), King Mongkut’s University of Technology North Bangkok (KMUT-NB), and Electric Vehicle Association of Thailand (EVAT). Over 60 members of the association include energy storage technology enthusiasts from various sectors ranging from academic, research institutes, public sectors, policymakers, and private industries.About National Center for Sustainable Transportation Technology (NCSTT)The National Center for Sustainable Transportation Technology (NCSTT), or Pusat Pengembangan Teknologi Transportasi Berkelanjutan, is from Indonesia and is a unique multidisciplinary research center focused on conducting, supporting and encouraging applied engineering and technology for transportation systems in Indonesia. NCSTT has been recognized globally as the research center which aims to foster the national transportation industry in developing national economics and welfare. NCSTT has built network linkages and research collaborations with national transportation stakeholders such as automotive, railway and aircraft industries, as well as research institutions and universities.About National Battery Research Institute (NBRI)The National Battery Research Institute (NBRI) was legally established on 17th December 2020 as The Center of Excellence Innovation of Battery and Renewable Energy Foundation, with Prof.Dr. Evvy Kartini as a Founder and Prof Alan J. Drew as Co-Founder. NBRI is Indonesia’s independent institute for electrochemical energy storage science and technology, supporting research, training, and education. NBRI aims to contribute to the overall research capacity and training environment in Indonesia in Battery Research. NBRI is a platform that brings together scientists, academicians, industry partners, the government and all stakeholders that focus on battery technology. The main goal of NBRI is to encourage and support a battery manufacturing industry using local resources, which will enable Indonesia to be independent in energy. The NBRI was supported by the UK Government’s Global Challenge Research Fund (GCRF), part of the Queen Mary University of London QR allocation.About Electric Vehicle Association of Philippines (eVAP)eVAP envisions a nation wherein the use of electric vehicles is highly promoted, encouraged and supported by its government and society to develop a transportation landscape that is one with the environment ecologically and economically. eVAP’s mission is to educate the public on environmental awareness, and the economic and ecological benefits of electric vehicles through the conduct of and/or participation in promotional activities.eVAP aims to accelerate society’s conversion from using gas-powered vehicles to electric vehicles and works with the government in the creation and implementation of legislation that will support and encourage the use of electric vehicles.About NanoMalaysiaNanoMalaysia Berhad was incorporated in 2011 as a company limited by guarantee (CLBG) under the Minister of Science, Technology and Innovation (MOSTI) to act as a business entity entrusted with nanotechnology commercialization activities. Some of its roles include commercialization of nanotechnology research and development, industrialization of nanotechnology, facilitation of investments in nanotechnology and human capital development in nanotechnology. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Kyrgyzstan Education Ministry Partners Singapore’s Marshall Cavendish Education with Plans to Adopt Singapore Maths and Science Education Titles in the Country ACN Newswire

Kyrgyzstan Education Ministry Partners Singapore’s Marshall Cavendish Education with Plans to Adopt Singapore Maths and Science Education Titles in the Country

ISSYK KUL, Kyrgyzstan, Aug 24, 2024 - (ACN Newswire via SeaPRwire.com) - The Ministry of Education and Science of the Kyrgyz Republic has partnered with Singapore's Marshall Cavendish Education (MCE) to introduce key training programmes and education resources to its schools throughout the country. The partnership seeks to instill key skillsets and content knowledge to strengthen teachers and students' abilities for the 21 st century.Kyrgyzstan is set to implement significant shifts in the hopes of increasing the educational quality and to increase the number of children that attend schools. The new titles by MCE will become available to over 2000 public schools and over 1.4 million students in the country. [1]Marshall Cavendish Education's English, Mathematics and Science series from kindergarten to grades 1 till 11 will soon be available in the local languages in Kyrgyzstan with its recent partnership with Okuu Kitebi Publishing House. Alongside the new syllabus and resources, MCE is set to conduct training and mentoring programmes that aim to support the Programme for International Student Assessment (PISA) competencies of teachers and students in subjects such as Mathematics and Science. Veteran educators from Singapore will present modules to help local educators and master trainers understand key concepts such as problem-solving skills and scientific inquiry, ultimately working towards inculcating a nationwide movement to achieve an improved and sustained academic performance regionally and internationally. The partnership will also include the introduction of artificial intelligence platform Cerebry, an engine and digital platform for teachers to integrate technology within their classrooms and enhance the learning experiences of the students. Unique questions and solutions are generated on demand, for each individual student.The launch of the partnership hosted at Issyk Kul, one of the deepest lakes in the world, saw more than 200 attendees who are key stakeholders in Kyrgyzstan's education ministry. It was also attended by Deputy Prime Minister Edil Baisalov, Minister of Education and Science of Kyrgyz Republic, Dogdurkul Kendirbaeva, UNICEF Representative to the Kyrgyz Republic, Samman J. Thapa and CEO, Times Publishing Limited Siew Peng Yim."In this partnership, our key goal is to provide a strong and consistent support and motivation to our educators in Kyrgyzstan. Singapore had faced tremendous challenges in its journey to achieve success in creating a world class education ecosystem. Marshall Cavendish Education will use the lessons we had learnt from the Singapore education transformation journey to provide the necessary resources and we will also tailor-made our solutions for Kyrgyzstan to help your students to achieve academic success and more importantly to build their confidence and to enjoy learning once more," shared Mr. Siew Peng Yim, CEO, Times Publishing Limited."The books published by Marshall Cavendish Education, which over its 60-year history have established collaborations with more than 90 countries and have been translated into 17 languages, are now available to us. We believe that the books they have published contributed to the journey Singapore has had with its education. After selecting, analyzing, and studying samples from many countries, we have decided to partner with MCE. We are ready to collaborate and aim for the partnership to bring Singapore educators to share their expertise on the education system" said Ms Dogdurkul Kendirbaeva, Minister of Education and Science of Kyrgyz Republic.About Marshall Cavendish EducationMarshall Cavendish Education (MCE) is a global education solutions provider dedicated to nurturing the joy of learning and preparing students for the future. We believe the best way to do so is by simplifying learning and listening to the needs of schools, teachers, students, and parents. MCE makes world-class educational content more accessible through a seamless experience that integrates both print and digital resources. We provide holistic and end-to-end solutions customised to the school's requirements, with professional development to help educators implement the curriculum. We've worked with ministries, policymakers, educators, and parents in over 90 countries, designing education solutions in 14 languages for Pre-K to 12. MCE is the only Asia-based publisher that is an endorsement partner of Cambridge International Education.www.mceducation.comFor Media Enquiries:Shahidah HamsahName:shahidahhamsah@mceducation.com[1] https://www.unicef.org/kyrgyzstan/media/8021/file/Education%20Joint%20Sector%20Review.pdfSOURCE: Marshall Cavendish Education Pte Ltd Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1 ACN Newswire

Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1

Cambridge, MA, Aug 24, 2024 - (ACN Newswire via SeaPRwire.com) - Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial change application for an updated formulation of its COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1."We appreciate the Ministry of Health, Labour and Welfare approval decision for our updated COVID-19 mRNA vaccine," said Stéphane Bancel, Chief Executive Officer of Moderna. "It is important that people are vaccinated with the latest updated COVID-19 vaccines that can protect against circulating strains. With COVID-19 vaccination becoming a routine inoculation similar to seasonal flu vaccines, individuals will be able to receive their updated COVID-19 vaccine alongside their flu vaccine this fall."In May 2024, a Japanese health ministry panel recommended that COVID-19 vaccines be updated to target the JN.1 family of Omicron subvariants for the 2024/2025 national immunization program (NIP). This guidance aligns with the recommendations from the World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) on the use of a monovalent JN.1 lineage for COVID-19 vaccine antigen composition.The NIP in Japan will offer COVID-19 vaccination to individuals aged 65 and older, as well as qualifying individuals aged 60 to 64.[1] Japan has the highest proportion of older adults worldwide, with approximately 30% of its population aged 65 and above. Given that respiratory viruses are a leading disease burden in people older than 65, NIPs are crucial in reducing the burden of disease and, ultimately, future pressure on the health system. Individuals requesting COVID-19 vaccination outside of the regular program will have the option of voluntary vaccination at their own expense.In July, Moderna entered into an agreement with Mitsubishi Tanabe Pharma Corporation to support the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including Moderna's COVID-19 vaccine, Spikevax.About ModernaModerna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.Moderna Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the authorization of Moderna's updated JN.1-targeting COVID-19 vaccine by the Ministry of Health Labor and Welfare in Japan; the ability of Moderna's updated COVID-19 vaccine to induce an immune response and provide protection against circulating SARS-CoV-2 variants; and Moderna's ability to supply its COVID-19 vaccine to support Japan's COVID-19 national immunization program. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna's control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading "Risk Factors" in Moderna's Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC's website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna's current expectations and speak only as of the date of this press release.Moderna ContactsMedia :International mediaLuke Mircea-WillatsSenior Director, International CommunicationsLuke.mirceawillats@modernatx.comModerna JapanCommunications & Mediajapan-pr@modernatx.comInvestors:Lavina TalukdarSenior Vice President & Head of Investor Relations+1 617-209-5834Lavina.Talukdar@modernatx.com[1]Qualifying individuals include those aged 60-64 with severe cardiac, renal or respiratory impairments that significantly restrict daily activities, or those with immune deficiencies due to Human Immunodeficiency Virus (HIV), making daily life exceedingly difficult.SOURCE: Moderna, Inc. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
吉尔吉斯斯坦教育部与新加坡Marshall Cavendish教育公司合作,计划在该国采用新加坡数学和科学教育教材 ACN Newswire

吉尔吉斯斯坦教育部与新加坡Marshall Cavendish教育公司合作,计划在该国采用新加坡数学和科学教育教材

吉尔吉斯斯坦伊塞克湖 , 2024年8月24日 - (亚太商讯 via SeaPRwire.com) - 吉尔吉斯共和国教育与科学部与新加坡Marshall Cavendish教育公司(MCE)合作,向全国各地的学校引入关键的培训项目和教育资源。此次合作旨在培养关键技能和知识内容,以增强教师和学生在21世纪的能力。吉尔吉斯斯坦将实施重大变革,旨在提高教育质量并增加入学儿童人数。通过MCE的新教材,超过2000所公立学校和140多万名学生将受益。[1]MCE的英语、数学和科学系列教材将从幼儿园到1至11年级,随着与Okuu Kitebi出版社的合作,逐步在吉尔吉斯斯坦以当地语言推出。除了新课程和资源,MCE还将开展培训和指导项目,旨在支持教师和学生在数学和科学等科目中的国际学生评估项目(PISA)能力。来自新加坡的资深教育工作者将提供模块,帮助当地教育工作者和主培训师理解关键概念,如问题解决技能和科学探究,最终推动全国范围内实现更好和持续的地区及国际学术表现。此次合作还将引入人工智能平台Cerebry,一个供教师在课堂中整合技术、增强学生学习体验的引擎和数字平台。该平台能够根据需求,为每个学生生成独特的问题和解决方案。**在世界最深的湖泊之一伊塞克湖举办的合作启动仪式上,吸引了200多位吉尔吉斯斯坦教育部的重要利益相关者出席。吉尔吉斯斯坦副总理Edil Baisalov、教育与科学部长Dogdurkul Kendirbaeva、联合国儿童基金会(UNICEF)驻吉尔吉斯斯坦代表Samman J. Thapa,以及时报出版有限公司首席执行官Siew Peng Yim也出席了此次活动。 “在这次合作中,我们的主要目标是为吉尔吉斯斯坦的教育工作者提供强有力且持续的支持和激励。新加坡在实现创建世界一流教育生态系统的过程中,面临了巨大的挑战。Marshall Cavendish教育公司将利用我们在新加坡教育改革过程中学到的经验,提供必要的资源,并且我们还将为吉尔吉斯斯坦量身定制解决方案,帮助学生取得学业上的成功,更重要的是重建他们的自信心,并重新享受学习的乐趣,”时报出版有限公司首席执行官Siew Peng Yim说道。 “Marshall Cavendish教育公司在其60年的历史中,已与90多个国家建立合作关系,出版的书籍已被翻译成17种语言,现在这些书籍已经为我们所用。我们相信,他们出版的书籍为新加坡的教育发展作出了贡献。经过对多个国家的样本进行挑选、分析和研究后,我们决定与MCE合作。我们准备好合作,并期待这一合作能够使新加坡教育工作者分享他们在教育系统方面的专业知识,”吉尔吉斯斯坦教育与科学部长Dogdurkul Kendirbaeva说道。**关于Marshall Cavendish教育公司 Marshall Cavendish教育公司(MCE)是一家全球教育解决方案提供商,致力于培养学习的乐趣,并为学生的未来做好准备。我们相信,最好的方法是简化学习,并倾听学校、教师、学生和家长的需求。MCE通过整合印刷和数字资源的无缝体验,使世界级的教育内容更加易于获取。我们提供整体和端到端的解决方案,定制化满足学校的需求,并提供专业发展支持,帮助教育工作者实施课程。我们已与90多个国家的教育部、政策制定者、教育工作者和家长合作,设计了适用于从学前教育到12年级的教育解决方案,涵盖14种语言。MCE是唯一一家与剑桥国际教育合作的亚洲出版商。www.mceducation.com媒体垂询:Shahidah HamsahName:shahidahhamsah@mceducation.com[1]https://www.unicef.org/kyrgyzstan/media/8021/file/Education%20Joint%20Sector%20Review.pdf来源:Marshall Cavendish Education Pte Ltd Copyright 2024 亚太商讯 via SeaPRwire.com.
More
日本厚生劳动省批准了莫德纳公司针对SARS-COV-2 JN.1变异株的COVID-19 mRNA疫苗的部分变更申请 ACN Newswire

日本厚生劳动省批准了莫德纳公司针对SARS-COV-2 JN.1变异株的COVID-19 mRNA疫苗的部分变更申请

马萨诸塞州剑桥, 2024年8月24日 - (亚太商讯 via SeaPRwire.com) - Moderna, Inc.(纳斯达克股票代码:MRNA)今日宣布,已获得日本厚生劳动省(MHLW)批准其COVID-19 mRNA疫苗Spikevax更新配方的部分变更申请,该疫苗针对SARS-CoV-2 JN.1变异株。 “我们感谢日本厚生劳动省对我们更新后的COVID-19 mRNA疫苗作出的批准决定,”莫德纳首席执行官Stéphane Bancel表示。“确保人们接种最新更新的COVID-19疫苗,以防范现有流行的毒株,这是至关重要的。随着COVID-19疫苗接种变得像季节性流感疫苗一样成为常规接种,个人将能够在今年秋季同时接种更新后的COVID-19疫苗和流感疫苗。” 2024年5月,日本卫生部的一个专家小组建议,将COVID-19疫苗更新为针对JN.1奥密克戎子变异株家族的疫苗,用于2024/2025年度的国家免疫计划(NIP)。这一指导意见与世界卫生组织(WHO)COVID-19疫苗成分技术咨询小组(TAG-CO-VAC)关于采用单价JN.1谱系作为COVID-19疫苗抗原成分的建议保持一致。日本的国家免疫计划(NIP)将为65岁及以上的人群,以及符合条件的60至64岁人群提供COVID-19疫苗接种服务。日本是全球老龄化比例最高的国家,大约30%的人口年龄在65岁及以上。鉴于呼吸道病毒是65岁以上人群的主要疾病负担,国家免疫计划对于减轻疾病负担以及未来减轻医疗系统压力至关重要。要求在常规计划之外接种COVID-19疫苗的个人可以选择自费自愿接种。 今年7月,莫德纳与三菱田边制药株式会社达成协议,共同推广莫德纳的mRNA呼吸道疫苗组合在日本的使用,其中包括Moderna的COVID-19疫苗Spikevax。 关于ModernaModerna是mRNA医学领域的开创者。 透过推动mRNA技术的发展,Moderna正在重新构想药物的制造方式,改变我们对待和预防疾病的方式。 透过在科学、技术和健康的交汇处工作超过十年,该公司以前所未有的速度和效率开发了药物,包括最早和最有效的COVID-19疫苗之一。Moderna的mRNA平台使得能够开发用于传染性疾病、免疫肿瘤学、罕见疾病和自体免疫疾病的治疗和疫苗。 凭借着独特的文化和由Moderna的价值观和思维方式推动的全球团队,Moderna致力于透过mRNA药物为人们提供最大的可能影响。 有关Moderna的更多信息,请访问modernatx.com,并在X(前身为Twitter)、Facebook、Instagram、YouTube和LinkedIn上与我们联系。前瞻性陈述本新闻稿包含根据1995年《私人证券诉讼改革法案》修订版的定义所指的前瞻性声明,包括以下声明:日本厚生劳动省授权Moderna更新的针对JN.1的COVID-19疫苗;Moderna更新后的COVID-19疫苗诱导免疫反应并提供针对流行SARS-CoV-2变种保护的能力;以及Moderna为支持日本COVID-19国家免疫计划而供应其COVID-19疫苗的能力。本新闻稿中的前瞻性声明既不构成承诺也不构成保证,您不应过度依赖这些前瞻性声明,因为这些声明涉及已知和未知的风险、不确定性和其他因素,其中许多超出了莫德纳的控制范围,可能导致实际结果与这些前瞻性声明所表达或暗示的内容存在重大差异。這些風險、不確定性和其他因素包括但不限於,Moderna在2023年12月31日結束的財政年度的年度報告中「風險因素」一節中描述的那些風險和不確定性,該報告已向 美國證券交易委員會(SEC)提交,並在Moderna隨後向SEC提交的文件中描述,這些文件可在SEC的網站www.sec.gov上取得。 除非法律規定,Moderna不承擔更新或修訂本新聞稿中包含的任何前瞻性陳述的意圖或責任,以反映新資訊、未來發展或其他情況。 這些前瞻性陳述是基於Moderna當前的期望,並僅截至本新聞稿的日期。联络方式:媒体:International mediaLuke Mircea-WillatsSenior Director, International CommunicationsLuke.mirceawillats@modernatx.comModerna JapanCommunications & Mediajapan-pr@modernatx.com投资者:Lavina TalukdarSenior Vice President & Head of Investor Relations+1 617-209-5834Lavina.Talukdar@modernatx.com[1] 符合条件的个人包括:60至64岁且患有严重心脏、肾脏或呼吸功能障碍,严重限制日常活动的个人,或因人类免疫缺陷病毒(HIV)导致免疫缺陷,致使日常生活极其困难的个人。来源:Moderna, Inc. Copyright 2024 亚太商讯 via SeaPRwire.com.
More
骏码半导体公布中期业绩 录得收益约109.0百万港元  LED封装胶销售量再增高 ACN Newswire

骏码半导体公布中期业绩 录得收益约109.0百万港元 LED封装胶销售量再增高

香港, 2024年8月23日 - (亚太商讯 via SeaPRwire.com) — 骏码半导体材料有限公司(「骏码半导体」或「公司」,连同其附属公司统称「集团」,股份代号:8490.HK)欣然宣布截至2024年6月30日止六个月(「该期间」)之未经审核业绩。于该期间,集团录得收益约109.0百万港元(2023年上半年:约101.6百万港元)。键合线产品录得收益增加10.7%至约 58.3百万港元(2023年上半年:约52.6百万港元),而封装胶产品的收益则轻微增加2.8%至约46.8百万港元(2023年上半年:约45.6百万港元)。收益增加乃由于本集团产品的销量增加所致。在2023年全球经济受压的背景下,人工智能产业链呈现快速增长势头。踏入2024年,人工智能将进一步推动晶片运算能力、储存容量和能源效率的提升,从而促进半导体架构和先进封装的创新,有关进步有望带来新的市场增量。根据国际半导体产业协会的「年中总半导体设备预测—OEM角度」报告,预测原设备制造商 (「OEM」)于2024年的全球半导体制造设备销售额将创下新产业纪录,达到1,090亿美元,按年增加3.4%。由前端及后端市场发展带动,半导体制造设备的销售额预计将持续增长至2025年,预计销售额将达到1,280亿美元新高。聚焦半导体封装行业,中国国内制造商正逐步从传统封装向先进封装技术拓展市场占有率。人工智能、高性能计算等新需求的带动下,需求不断增长,加速了中国半导体产业的战略布局,继而促进了该拓展。尤其是在先进封装所需的材料方面,由于其技术复杂度高、制程影响大、国产率相对较低,因此受到业界的高度关注。展望未来,鉴于人工智能的快速发展,本集团将继续寻求新的业务合作,并专注于先进半导体材料的创新,以应用于电动汽车、微型LED显示、人工智能及5G通信行业。此外,集团亦会投放更多资源于5G及半导体产业的上游封装材料,预期这将成为本集团的另一增长领域。展望未来,尽管国际形势不明朗,董事会坚信集团在半导体封装材料行业的既有地位、竞争优势及灵活的业务策略,将可克服复杂环境影响,实现长期增长,为股东带来最大回报。-完-关于骏码半导体材料有限公司骏码半导体材料有限公司(「骏码半导体」)是国内半导体封装材料行业龙头企业之一,由周振基教授及周博轩博士于2006年共同创立,总部位于香港科学园区,研发及制造中心设在广东汕头,业务多点分布大湾区及华东地区。骏码半导体是一家专业从事研发、制造及销售高精密键合线、灌封材料、粘结材料等半导体封装专用物料的高新材料提供方。此新闻稿由慧悦公共关系顾问集团有限公司代表骏码半导体材料有限公司发布如有垂询,请联络慧悦公共关系顾问集团有限公司:Karena Ke电话:(852)9346-2934电邮:karena.ke@intelligentjoy.com Copyright 2024 亚太商讯 via SeaPRwire.com.
More

AI提效显著,上市以来连续盈利,粉笔2024中期净利润增幅240.9%

香港, 2024年8月23日 - (亚太商讯 via SeaPRwire.com) — 8月23日,粉笔(02469.HK)发布2024年中期业绩报告。截至2024年6月30日,粉笔实现营收16.3亿元,与去年同期基本持平;净利润为2.8亿元,同比大涨240.9%,经调整净利润3.5亿元,同比增长21.2%,上市以来粉笔连续三份财报净利润保持快速增长,盈利能力亮眼。粉笔创始人、CEO张小龙表示,粉笔将会继续努力,在做好品质基础上,平衡好产品质量和收入规模关系,始终把品质和效率放在第一位,同时持续加大对教研技术投入,尤其是AI技术的投入。“我们坚信对于教育培训类产品,把品质做好一定会带来市场占有率和收入规模增加,这种收入才是健康可持续有口碑的收入。只要坚持做正确的事,一定会迎来品质规模利润的良性循环,以此回报各位用户和投资人对我们的支持和信任。”1、毛利率、净利率双双提升,发展稳健向好2024年,“稳就业”依旧是主旋律之一。据信达证券分析,国考+省考招录人数稳定增长,报名人数弹性更强,2024年国考通过资格审查人数同增21.3%,实际参加考试人数同增47.7%,省考报名人数同增13.1%,在当前的就业环境下,公考热情有望持续提升。考生参培需求预计持续释放。从公告披露数据来看,作为行业头部企业,粉笔各项业务有序发展。截至2024年6月30日,粉笔平均月活跃用户为920万。据粉笔介绍,OMO模式已经在其小班课程产品中全面普及,充分整合线上线下优质教育资源,为用户提供多元的产品选择,和更具个性化的学习体验。依托坚实的用户基础和优越的产品力,粉笔业务潜力有望得到进一步开发。2024年上半年,粉笔毛利为8.8亿元,同比增长3.2%,毛利率从去年同期的50.9%增加至54.2%;净利润率为17%,去年同期为4.8%,增幅显著,体现公司产品市场竞争力增强,盈利水平保持强劲增长。2024年上半年,粉笔整体师均收入贡献为51.8万元,经营效率不断提升。此外,报告期内,粉笔图书业务实现收入2.5亿元,在总营收中占比与去年同期持平,为用户提供更全面的服务的同时,也保证了收入的多样性。2、AI应用加速落地,锁定优势地位2024年,粉笔锚定科技创新,人工智能研发再上一个台阶,推出了首个职教领域垂域大模型,并落地应用粉笔AI老师,不断提升自身技术竞争力,为下半年业绩增长提前锁定发展空间。报告期内,粉笔研发开支为1.1亿元。财报显示,得益于人工智能技术及其他在线技术赋能大幅提升授课效率,2024年上半年,粉笔收入成本为7.5亿元,与去年同期的8.3亿元相比缩减了9.6%。尤其是培训服务相关成本,缩减了11.6%至5.8亿元。粉笔AI应用已经融入教研、教学、运营的各环节中,在面试点评、笔试辅导、客服等领域提供支持。在AI助力下,粉笔行业优势地位凸显。据介绍,2021年2月,一位精品班辅导老师同期可以服务40人左右,目前,一位老师同期最高可服务150人,效率提升可达275%。不光是效率,用户体验也随之提升。在预测分功能辅助下,2022年省联考行测到2024年省联考行测,精品全程班用户对应提分涨幅可以达到40%。据媒体报道,粉笔AI矩阵还在不断扩展,包括申论AI老师、面试AI老师以及事业单位、教师项目的AI老师在内的产品正在开发中,有望成为业绩发展新的曲线。在坚定技术投入的基础上,粉笔始终对长期增长前景充满信心。今年5月,粉笔公布了一项回购计划,预计在2025年5月12日前不时在公开市场上购回价值总额不超过3亿港元的公司普通股。据悉,截至2024年8月9日,粉笔已回购并注销普通股5423万股,累计回购金额约2.3亿港币。粉笔表示,预计公司的收入可以稳健增长,在维持高质量教学品质的前提下,利润率和运营效率仍有进一步优化的空间。粉笔发展前景也获多家机构认可,天风证券、信达证券、方正证券、国泰君安等均给予粉笔“看好”“推荐”等评级。 Copyright 2024 亚太商讯 via SeaPRwire.com.
More
乐普生物公布2024年中期业绩 ADC管线取得重大进展  核心产品营收大增一倍 ACN Newswire

乐普生物公布2024年中期业绩 ADC管线取得重大进展 核心产品营收大增一倍

香港, 2024年8月22日 - (亚太商讯 via SeaPRwire.com) —聚焦于肿瘤治疗领域的创新型生物制药公司──乐普生物科技股份有限公司(「乐普生物」或「公司」,股份代号:2157.HK) 公布2024年中期业绩。作为一家立足中国、面向全球的聚焦于肿瘤治疗领域(尤其是靶向治疗及免疫治疗)的创新型生物制药企业。乐普生物致力于通过先进的ADC技术开发平台开发创新型ADC,并旨在开发出更优化、更创新的药物,更好地填补癌症患者的临床需求缺口。公司致力于通过内部研发与战略合作相结合的方式持续开发市场差异化管线,加强自主生产能力。目前,乐普生物已战略性布局了多个肿瘤产品管线。就临床阶段候选药物而言,公司的产品中有一种临床 / 商业化阶段候选药物;七种临床阶段候选药物(包括一种透过合营企业共同开发的药物);及三种临床阶段的候选药物的联合疗法。其中一种候选药物已获得两种靶向适应症的上市批准,其他适应症临床试验正在进行中。商业化稳定再超亿元 核心产品销售较去年同期增加一倍于报告期内,公司在推进产品管线及业务营运方面均取得重大进展,其中核心产品普佑恒®(普特利单抗注射液)的销售收入达人民币94.8百万元,较2023年同期增加一倍,为公司收益人民币133.3百万元之主要贡献。ADC管线及其与癌症免疫的联合疗法亦取得多项重大进展。而于创新平台研发的候选药物临床前获得良好数据。于2023年4月,普特利单抗已成功获纳入用于治疗黑色素瘤和MSI-H/dMMR实体瘤的2023年CSCO及CSGO指南,表明临床KOL的高度认可。公司积极发展与各种业务渠道合作伙伴的合作关系。截至2024年6月30日,已在26个省份的采购平台上完成了招标程序,并已通过各种销售渠道覆盖约78个城市,将进一步扩大销售网络。ADC管线及其与癌症免疫的联合疗法取得重大进展公司的ADC候选药物包括MRG003、MRG002、MRG004A、MRG001、MRG006A及CMG901。ADC管线及其与癌症免疫的联合疗法在上半年取得了重大进展。- MRG003:目前已完成NPC IIb期注册性临床研究的患者入组,预期将于2024年下半年于中国申报NDA。于2024年7月,公司已就MRG003用于治疗R/M NPC于美国获FDA授予BTD。MRG003与普佑恒®(普特利单抗注射液)的联合疗法:公司正在进行MRG003与普特利单抗联合治疗实体瘤的I/II期试验,并已完成I期试验。公司已观察到良好的初步数据,该等数据已在2024年ASCO年会上以口头汇报形式呈现。公司目前正在进行II期试验并已观察到良好的数据,该等数据计划于2024年ESMO亚洲年会上呈现。- MRG002:已于中国完成HER2高表达BC肝转移II期关键临床试验的患者入组,并观察到良好数据,预期将于2024年CSCO上呈现。同时,公司正在进行HER2阳性BC的III期临床试验。MRG002与普佑恒®(普特利单抗注射液)的联合疗法:公司正在进行MRG002与普特利单抗联合治疗HER2表达实体瘤患者的II期试验,并已于UC患者中观察到良好的初步数据,预期将在2024年ESMO大会上呈现。- MRG004A:公司目前正在美国及中国进行实体瘤I期临床研究,并已在PC、TNBC及CC中观察到良好数据。实体瘤的相关初步I期数据已在2024年ASCO年会上以口头汇报形式呈现。于2024年3月,MRG004A已获FDA授予FTD,用于治疗经过过往批准的疗法治疗的复发性或难治性PC。公司正在扩展I期临床试验PC患者亚组,以进一步探索MRG004A用于PC的更多潜力。- MRG006A:公司已于2024年AACR年会上公布良好的临床前数据。于临床前研究中,MRG006A在多种CDX模型及HCC PDX模型中展现出强大的剂量依赖性的对肿瘤的生长抑制作用。同时,MRG006A亦在探索性毒理学研究中表现出良好的耐受性。根据良好的临床前表现,公司已于中国获得IND批准,且目前正在进行I期临床研究,而该研究已于2024年8月实现首例患者入组。临床前:布局创新平台和创新靶点公司持续致力于建立和开发新型技术平台。除临床验证的vc-MMAE平台外,亦已为ADC候选药物开发多个创新的链接体- 有效载荷平台,包括Hi-TOPi平台及其他早期阶段的平台。于报告期内,公司的创新ADC平台及T细胞衔接器平台TOPAbody取得了重大进展。依托该等创新平台,已开发出两款ADC候选药物,分别为具有全球首创新药潜力的MRG006A及具有全球同类最优潜力的MRG007,以及新一代T细胞激动性抗体CTM012。公司已观察到良好的临床前研究数据,并已于中国获得MRG006A的IND批准。同时,亦正在高效推进MRG007及CTM012进入临床研究阶段。MRG006A及TOPAbody平台的临床前数据已于2024年4月在AACR年会上呈现。未来展望展望2024年下半年,公司将继续加快两款主要ADC产品MRG003及MRG002的开发,迈向下一个里程碑。公司预期将于2024年下半年于中国就MRG003申报NDA,并将努力加快审批进程。公司亦将探索MRG004A及MRG006A等其他创新候选药物的更多潜在临床价值。同时,不断探索管线内的联合疗法的潜在疗效,以为更多患者带来临床效益。就创新分子而言,致力加强建设创新平台,并全力推进创新分子CTM012及MRG007进入临床研究阶段。2024年,公司将致力于深化市场营销及商业化,并积极扩大在中国的市场足迹及产品知名度。这包括促进普佑恒®(普特利单抗注射液)的市场准入,继续加快各级市场渗透,以进一步扩大市场份额。同时,公司将寻求通过各种方式提升品牌形象及市场对公司产品的认识。在国际方面,公司将加大在全球市场的拓展力度。由于ADC平台已获跨国公司认可,预期公司的其他ADC产品将有更大的业务发展机会。日后,公司将坚持不懈地扩大国际网络,并通过多项策略探索新的业务开发合作机会,以促进我们的发展及成功。 Copyright 2024 亚太商讯 via SeaPRwire.com.
More

Weichai Power: Net profit attributable to shareholders of the parent increased by 50%

HONG KONG, Aug 23, 2024 - (ACN Newswire via SeaPRwire.com) - On 22 August 2024, Weichai Power (000338.SZ; 2338.HK) released its semi-annual report. According to the announcement, in the first half of 2024, Weichai Power achieved income of RMB 112.49 billion, a year-on-year increase of 6.0%; net profit attributable to shareholders of the parent was RMB 5.90 billion, a year-on-year increase of 51.4%; and net profit attributable to shareholders of the parent after deducting non-recurring profit and loss was RMB 5.48 billion, a year-on-year increase of 51.8%. At the same time, the Company announced its interim dividend payout plan for 2024, with a cash dividend ratio increased to 55%.Power System: Empowering and expanding product advantages with technology, steadily increasing market shareWeichai Power insisted on independent innovation, continuously accelerated the commercialization of scientific and technological achievements, and promoted the expansion of differentiated product advantages. It has launched the world's first diesel engine with body thermal efficiency of 53.09%, setting a new world record for four consecutive times; and launched a new generation of LNG engines, with overall improvements in power, reliability, economy, and comfort. In the first half of 2024, total engine sales volume of Weichai Power was approximately 400 thousand, representing a year-on-year increase of 9.8%. Among them, sales volume of heavy-duty truck engines reached approximately 161 thousand units, with a market share of 40.5%; market share of LNG heavy-duty truck engines reached 63.1%; and market share of 6x4 tractor-trailer engines with 500 horsepower and above reached 44.6%. Besides, the sales volume of M series engines of the Company reached approximately 3,600 units, and the product structure continued to improve, with overseas revenue accounting for 75.6%.Heavy-duty truck: Continued breakthroughs in segment markets, significant improvement in operational quality.Benefiting from the recovery of domestic demand and the gradual manifestation of China's heavy-duty truck export competitiveness, the heavy-duty truck industry has shown a trend of recovery. Shaanxi Heavy-duty Automobile continuously improves its product market competitiveness, with a focus on breaking through advantageous segment markets, achieving improvements in both production and sales scale and operational efficiency. In the first half of 2024, Shaanxi Heavy-duty Automobile sold approximately 63 thousand heavy-duty trucks, a year-on-year increase of 3.6%. Among them, sales volume of LNG heavy-duty trucks reached approximately 17 thousand units, an increase of 134.3% year-on-year; sales volume of new energy heavy-duty trucks reached 2,840 units, a year-on-year increase of more than doubling. At the same time, Shaanxi Heavy-duty Automobile has deeply explored the potential of overseas markets, with export volume of heavy-duty trucks reaching approximately 30 thousand units, a year-on-year increase of 15%, realizing the highest level in the same period in history.Agricultural equipment: Actively responding to the rural revitalization strategy, leading the industry's high-end transformation.Weichai Lovol Intelligent Agriculture focused on building three core capabilities of "smart agricultural machinery, precision agriculture, and digital agricultural services", actively promoted product transformation and upgrading, and leads China's agricultural machinery industry towards high end with its own high-quality development. In the first half of 2024, Weichai Lovol Intelligent Agriculture sold approximately 77 thousand units of various types of agricultural machinery, a year-on-year increase of 17.5%; the achievements of large-scale and high-end transformation were highlighted, with the proportion of tractors above 100 horsepower increasing by 8 percentage points year on year and the proportion of tractors above 200 horsepower increasing by 3 percentage points year on year. Weichai Lovol Intelligent Agriculture achieved revenue of approximately RMB 9.8 billion, a year-on-year increase of 28.1%, reaching the best level in the same period in history; achieved a net profit of approximately RMB 560 million, a year-on-year increase of 34.8%.Intelligent logistics: Revenue reaching a new historical high, significant increase in profitability.In the first half of 2024, Weichai Power's holding subsidiary, KION Group, achieved revenue of approximately EUR 5.74 billion, a year-on-year increase of 2%, reaching a new high in the same period in history. Among them, the forklift business achieved revenue of approximately EUR 4.31 billion, and the supply chain solutions business achieved revenue of approximately EUR 1.45 billion. Benefiting from improved operating quality and increased operational efficiency, KION Group's profitability continues to strengthen. In the first half of 2024, it achieved a net profit of approximately EUR 180 million, a year-on-year increase of 24.1%; the adjusted EBIT margin was approximately 7.8%, representing an increase of 1.6 percentage points year on year. Based on the strong development momentum in the first half of the year, KION Group has further confirmed its full-year performance outlook, defining its continued growth and positive operating expectations.In future, the Company will continue to seize the opportunities brought by the new quality productive forces and the transition from old to new drivers of growth, focus on value creation, reform deepening, layout optimization, and technological innovation, firmly promote in-depth reforms, strengthen development quality, reinforce development vitality and boost growth momentum. Changing gears and speed up to enhance growth force and gathering strength to promote development, the Company is accelerating to build a world-class company. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
InfoComm India 2024: The Largest Edition of the Pro AV Exhibition to Date ACN Newswire

InfoComm India 2024: The Largest Edition of the Pro AV Exhibition to Date

MUMBAI, INDIA, Aug 23, 2024 - (ACN Newswire via SeaPRwire.com) - InfoComm India, India’s foremost professional audiovisual (Pro AV) exhibition, is set to return to Mumbai from 3-5 September 2024 at the Jio World Convention Centre (JWCC). This year, InfoComm India 2024 expands beyond Pavilions 1 to 3 at JWCC, incorporating Jasmine Hall (at Level 3) for an even larger showcase of innovative solutions. It will showcase over 250 brands from more than 10 countries, including 35 first-time exhibitors. Registration is now open for professionals and businesses looking to deepen their Pro AV expertise.InfoComm India 2024, 3-5 September 2024, Jio World Convention Center, Mumbai | Attend over 48 free summit sessions, across 14 tracks, featuring insights from more than 50 industry leaders.Visitors can discover a plethora of solutions ranging from the latest in digital signage, to intelligent video conference systems, from artificial intelligence (AI) in LED virtual production to naked eye 3D displays, smart classroom solutions, interactive immersive projection mapping and more catering to a wide range of sectors such as education, finance, live events, urban development & smart cities. The exhibition will showcase top-tier products and innovations from renowned global brands and emerging industry players, including AERO, BENQ, Crestron, Harman, QSYS, Barco, AET, Samsung, and PeopleLink, along with WACOM, DVSI, Neotouch, Yotech Infocom, Onfinity Technologies and 30 more who are exhibiting for the first time at InfoComm India.With an expanded show floor space at Jasmine Hall, visitors can look forward to even more innovators in the Pro AV and technology space including TOYO, 4 Squares Corporation, Altex, Black Box and Wah Lee to name a few. AVIXA will also be making its presence felt at Jasmine Hall with interactive and knowledge-packed seminars hosted at its booth throughout the three days.InfoComm India 2024 expands beyond Pavilions 1 to 3 at JWCC, incorporating Jasmine Hall (at Level 3) for an even larger showcase of innovative solutions.The 2024 InfoComm India Summit will offer over 48 free-to-attend seminars across 14 specialized tracks led by over 50 industry leaders as speakers. A glimpse of the exciting lineup of sessions includes a kick-off overview “Navigating New Horizons: Insights and Innovations Shaping India’s Pro AV Landscape” led by David Labuskes, CTS, CAE, RCDD, Executive Director and CEO, AVIXA , ‘Live Events & Experiential Planning’ exploring Pro AV application for live events, as well as industry-focused sessions dedicated to smart cities, hospitality, and education sectors like "Future of Learning Spaces", “Securing the Future: Cybersecurity Strategies, Economics, and Risk Management”, Digital Signage in the AI-age which explores real-world strategies using AI, VR, and digital platforms for immersive experiences."India's digital transformation is truly inspiring," said June Ko, Executive Director of InfoComm India. "We see a vibrant energy and a thirst for innovation across the country. InfoComm India 2024 is our way of bringing together the brilliant minds and passionate hearts that are shaping this new era of technology in India. We envision InfoComm India as the premier destination for the Pro AV community to exchange ideas, foster partnerships, and collectively drive the industry forward.”Connection is at the heart of InfoComm India 2024. A host of networking opportunities are designed to connect attendees with industry experts, thought leaders, and peers. They include the Breakfast Networking Hour at Luminary Lounge (Jasmine Hall) on 2 and 3 September, 9.30am to 10.00am; Flashtrack seminars and networking events at AVIXA booth; daily New Technology and Products Show Floor Tours and more.InfoComm India 2024 will showcase over 250 brands, with 35 first-time exhibitors.For full details on exhibitors, products, summit agenda, registration, and sponsorship opportunities, visit www.infocomm-india.comTo access more press information of InfoComm India 2024, please visit: Digital Press Office KitFor more information, please contact:Rest of the WorldAngieEngMarketing DirectorInfoCommAsiaPteLtdangieeng@infocommasia.comIndiaSooraj DhawanDirectorFalcon Exhibitions Pvt. Ltd.sooraj@falconfirst.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Web3 with Tobi & Brent to Host Exclusive Networking Event and AfterParty During Token2049 Singapore ACN Newswire

Web3 with Tobi & Brent to Host Exclusive Networking Event and AfterParty During Token2049 Singapore

Summary: Coinciding with F1 week and TOKEN2049 at the iconic Marina Bay Sands in Singapore, this edition of the global event series “Web3 with Tobi & Brent” will serve as a hub for the Web3 community, facilitating connections and idea exchanges among industry leaders and developers.The event will feature a headline set by renowned DJ Dillon Francis, with artists Jade Rasif, Nicole Chen, and CeVie joining the lineup to offer unparalleled entertainment alongside networking opportunities at the iconic MARQUEE Nightclub. Co-hosted by prominent Web3 entities such as 280 Capital, Biptap, Cytonic, BitcoinOS and TBV, and supported by key partners like Limewire, Altcoin Daily, ZkPass, Ripple, 10X Capital, yourPRstrategist (YPRS), XDC Plug and Play, FOMO Ventures, ShibaDino, KINO, LBank, and Bitrue, the event will attract significant industry figures and offer unique insights into the Web3 ecosystem.SINGAPORE, Aug 23, 2024 - (ACN Newswire via SeaPRwire.com) - "Web3 with Tobi & Brent," a premier event series in the Web3 community, is set to host a renowned networking event and afterparty on September 17, 2024, at MARQUEE, Marina Bay Sands, Singapore. Coinciding with the TOKEN2049 conference, the event is strategically delivering high-value networking with the signature “Web3 with Tobi & Brent” party experience. Entrepreneurs, investors, developers and industry KOLs are set to come together for a night to be remembered.The event begins at 9PM with a networking session, followed by an afterparty at the MARQUEE Nightclub from 10:00 PM until late. Following a lineup of incredible artists including CeVie, Jade Rasif and Nicole Chen, guests can look forward to a headlining performance by the internationally acclaimed DJ, Dillon Francis. Known not only for his electrifying beats but also for his comedic humor, Dillon has secured his place as a crowd favorite having performed at some of the world’s biggest music festivals, including Coachella, Tomorrowland, and EDC. The combination of top-tier attendees, entertainment, and service promise an exceptional experience that will make it an unforgettable night.The event is co-hosted by 280 Capital, a leading Web3 venture arm with $2 billion in assets under management; Biptap, the first decentralized, non-custody multichain crypto debit card and payment offramp solution; Cytonic, the world‘s first Multi-Virtual-Machine Blockchain, combining Bitcoin, Ethereum and Solana in a single chain; BitcoinOS, the Bitcoin Superchain with interoperable rollups with near trustless rails for BTC & Bitcoin-native assets; and TBV, an early-stage Web3 venture capital fund investing in top-tier projects globally. Supporting partners include ZkPass, LimeWire, 10X Capital, Bitrue, KINO, Ripple,, LBank, ShibaDino, FOMO Ventures, Altcoin Daily, XDC powered by Plug and Play, BoomFi, Hivello, Freename, Aquanow, FunFair Ventures, Petastic, Morningstar Ventures, KXVC and Founders Launchpad.“Web3 with Tobi & Brent” is also supported by prominent players in Web3 PR and media such as yourPRstrategist (YPRS), Cointelegraph, Cryptopolitan, CoinsCapture, Coinstelegram, Luna PR, MediaX Agency, and European Kid as well as community partners like Association Blockchain Asia, Cryptocurrency PH, Unity Labs, Arts DAO, and Crypto World Community and CryptoMondays Lisbon, which further amplify its reach. With its extensive network and high-profile partnerships, the event stands out as a key highlight of TOKEN2049, attracting industry insiders and enthusiasts alike.Due to the high demand and limited capacity guests are advised to arrive early, with doors opening at 9:00PM, to ensure entry.For more information and to register, visit: https://lu.ma/web3tobiandbrenttoken2049SG For the latest updates, join the Telegram group: https://t.me/+5KzXYg2cridmOGRlAbout Web3 with Tobi & BrentWeb3 with Tobi & Brent is a premier event series in the Web3 community, bringing together key industry figures for networking and collaboration. With a focus on fostering connections and sharing insights, these events serve as a hub for innovation and growth in the blockchain space.Company URL: https://linktr.ee/tobiandbrentContact: skye@tbv.xyzPR Contact: pr@yourPRstrategist.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
2nd ASEAN Battery Technology Conference Announces New Collaborations and Expansion to Strengthen Southeast Asia Battery Ecosystem ACN Newswire

2nd ASEAN Battery Technology Conference Announces New Collaborations and Expansion to Strengthen Southeast Asia Battery Ecosystem

SINGAPORE, Aug 23, 2024 - (ACN Newswire via SeaPRwire.com) - The 2nd ASEAN Battery Technology Conference (ABTC) returned and strengthened the commitment to develop a close knitted battery development ecosystem among the Southeast Asian countries. Hosted in Singapore this year by the Singapore Battery Consortium at Singapore at the Shangri-La Rasa Sentosa between 21st and 23rd August 2024.The conference is also jointly organised by the alliance of leading battery associations in the region - the Thailand Energy Storage Technology Association, the National Battery Research Institute, the National Center for Sustainable Transportation Technology, NanoMalaysia, and the Electric Vehicle Association of the Philippines.Dr. Pimpa Limthongkul, Co-Chairman of ABTC and President of the Thailand Energy Storage Technology Association, said, "This year we are excited to see the expansion of what we have achieved since we last gathered together last year in Bali. Our alliance has grown from three to now six battery associations in Southeast Asia and we will continue to grow in strength. Witnessing the collaborations between the battery associations, private sector and academia is a celebration of how we are moving forward together to drive innovation for a more connected and eco-friendly future in the region.”On the second day of the conference, over 250 participants and the six leading battery associations in Southeast Asia witnessed the signing of three new Memorandums of Understanding or MoUs that will further the development of batteries in the region. From L to R: Prof. Nonglak Meethong (Professor, Khon Kaen University), Mr. Larry Poon (Business Development Manager, INV CORPORATION PTE. LTD.), Dr. Rezal Khairi Bin Ahmad (CEO, NanoMalaysia Berhad), Mr. Bryan Oh (CEO, NEU Battery Materials Pte Ltd) Mr. Freddie Kim (Managing Director, SAMSUNG SDI SOUTHEAST ASIA), Dr. Sing Yang Chiam, Technical Director Singapore Battery Consortium.Three Memorandums of UnderstandingGigafactory Malaysia (GMSB) and NEU Battery Materials (NEU) to Collaborate on Lithium Battery Recycling DevelopmentThe collaboration will focus on developing “Gigafactory” level operations and manufacturing of innovative battery technologies incorporating nanomaterials for mobility and stationary applications. This collaboration is the progression of the Memorandum of Understanding (“Memorandum”) signed in Bali, Indonesia at the 2023 ASEAN Battery and Electric Vehicle Technology Conference (ABEVTC) to promote cross-country collaboration within ASEAN on battery technology.Singapore-based, NEU, who are specialists in LFP battery recycling will ensure a steady supply of recycled battery material, like lithium carbonate and other metals are made available to GMSB’s Hydrogen-Electric-Vehicle-Battery (HEBATT) Centre for performance testing. GMSB is a subsidiary of NanoMalaysia.The testing of the recycled material is to ensure their viability and sustainability within the Malaysia battery ecosystem, which would expand to localised development of a lithium battery recycling ecosystem for the ASEAN region. NEU and GMSB will facilitate this supply and development based on spent battery material being used in an end-to-end ecosystem.This will also pave the way for the exploration of a joint-development programme for improved recycling efficiency between these two companies.Gigafactory Malaysia Sdn Bhd (GMSB) and Khon Khean University (KKU) to Collaborate on Manufacturing of Cells Developed by GMSBGMSB’s and KKU’s collaboration will leverage their joint expertise and resources, with KKU acting as the outsourced manufacturer for batteries developed by GMSB. The collaboration will also provide knowledge sharing in battery testing and certification that will lead to productivity advancements at GMSB's Hydrogen-Electric-Vehicle-Battery (HEBATT) Centre in Malaysia.This Memorandum of Understanding (MoU) is an extension of an agreement signed at the 2023 ASEAN Battery and Electric Vehicle Technology Conference (ABEVTC) in Bali, which involved key organisations from Singapore, Indonesia, Thailand, Malaysia, and the Philippines.Aligned with the ASEAN Battery Network's mission, this MoU aims to strengthen battery technology development within ASEAN.Institute of Materials Research and Engineering (IMRE), Singapore and INV Corporation to collaborate on Joint Research to Develop Hybrid Battery SeparatorsA Research Collaborative Agreement will be signed between the Institute of Materials Research and Engineering in Singapore and INV to develop the next generation hybrid battery separators, which will address the challenges of safety faced by current rechargeable batteries.This collaboration seeks to play on the strengths and IPs in solid state batteries developed in Singapore. INV is headquartered in Singapore and is the largest battery separator film manufacturer in the world. Its production plants are in Sweden and Malaysia.Samsung SDI Southeast Asia ExpansionSamsung SDI, Korean high performance battery manufacturer began production in Southeast Asia with its first facility in Malaysia in 1992 and built a second plant in Vietnam in 2010. It will also open a second plant in Malaysia in 2025.To better support its customers in the region, it recently opened two sales offices in Vietnam and Singapore, with Singapore as the region sales headquarters for South East Asia.It is also planning to open new sales offices in Malaysia, Indonesia, Thailand and Philippines.Samsung SDI’s core battery product in Southeast Asia is the “Prime Battery for Maximum Experience” or PRiMX for short. PRiMX batteries are high on performance, reliability and safety using high nickel (low cobalt) cathode and silicon anode.As the company's vision, expect to make the world greener and sustainable through innovative technology.Hosting of the ABTC is rotated among the co-organisers. In 2025, TESTA will host the ABTC in Thailand.For more information on the programme agenda, please visit our official site: https://reg.eventnook.com/event/ABTC2024/homeThe conference's anchor sponsor is Hyundai Motor Group Innovation Center Singapore (HMGICS), with the gala dinner sponsored by INV Corporation Pte Ltd.Gold sponsors include Amphenol Communications Solutions, Quantel Pte Ltd, Infineon Technologies Asia Pacific Pte Ltd, and Gotion Singapore Pte Ltd, while silver sponsors are Concord New Energy Group Limited, Kewell Technology Co.,Ltd., Metrohm Singapore Pte Ltd, TME Systems Pte Ltd.Additional sponsors include Samsung SDI Southeast Asia Pte. Ltd, Siemens Industry Software Pte Ltd, UL Standards & Engagement, and NEWARE Technology Limited. Publicity partners are the EV Association of Singapore, EV Association of Malaysia, and Turn Off Turn On Ventures.Media ContactPRecious Communicationsabtc@preciouscomms.comAbout ASEAN Battery Technology ConferenceASEAN Battery Technology Conference (ABTC) stands out as the premier battery conference in ASEAN, attracting an audience of over 250 participants. We look forward to engaging with a diverse range of participants, including cell manufacturers, pack integrators, and recycling companies. The mission of ABTC is to bring together regional battery expertise, creating unique opportunities within the global battery value chain.The primary objective of ABTC is to foster collaboration among stakeholders in the battery industry. We aim to facilitate insightful discussions covering various topics, such as advanced battery materials, prototyping, cell-to-pack technologies, and recycling strategies.In addition to these focal points, the conference will explore related aspects such as standards, interoperability, and the ongoing evolution of battery safety technology.Organisers of ABTCAbout Singapore Battery ConsortiumSingapore Battery Consortium (SBC) aims to foster strategic R&D partnerships amongst public research performers and industry players in developing and advancing battery technologies. SBC aims to develop and catalyze the local ecosystem in battery-related technologies through this platform. It is hosted at A*STAR and supported by the National Research Foundation Singapore (NRF). Over the past decade, commercial interest in battery development has been on the rise, keeping pace with demand for better battery performance and different performance characteristics for increasingly complex mobility and portable devices. To meet this demand, the Singapore Battery Consortium will bring research outcomes from our laboratories into the market by enabling researchers to understand business requirements, while giving companies access to the latest battery research and technologies to augment their product development efforts.About Thailand Energy Storage Technology Association (TESTA)TESTA or THAILAND ENERGY STORAGE TECHNOLOGY ASSOCIATION aims to help connect stakeholders, educate the public, promote understanding, and nurture technological advancements in energy storage technologies in Thailand. TESTA was officially registered on January 25, 2021, by 5 founding institutes including the National Science and Technology Development Agency (NSTDA), Khon Kaen University (KKU), King Mongkut’s University of Technology Thonburi (KMUTT), King Mongkut’s University of Technology North Bangkok (KMUT-NB), and Electric Vehicle Association of Thailand (EVAT). Over 60 members of the association include energy storage technology enthusiasts from various sectors ranging from academic, research institutes, public sectors, policymakers, and private industries.About National Center for Sustainable Transportation Technology (NCSTT)The National Center for Sustainable Transportation Technology (NCSTT), or Pusat Pengembangan Teknologi Transportasi Berkelanjutan, is from Indonesia and is a unique multidisciplinary research center focused on conducting, supporting and encouraging applied engineering and technology for transportation systems in Indonesia. NCSTT has been recognized globally as the research center which aims to foster the national transportation industry in developing national economics and welfare. NCSTT has built network linkages and research collaborations with national transportation stakeholders such as automotive, railway and aircraft industries, as well as research institutions and universities.About National Battery Research Institute (NBRI)The National Battery Research Institute (NBRI) was legally established on 17th December 2020 as The Center of Excellence Innovation of Battery and Renewable Energy Foundation, with Prof.Dr. Evvy Kartini as a Founder and Prof Alan J. Drew as Co-Founder. NBRI is Indonesia’s independent institute for electrochemical energy storage science and technology, supporting research, training, and education. NBRI aims to contribute to the overall research capacity and training environment in Indonesia in Battery Research. NBRI is a platform that brings together scientists, academicians, industry partners, the government and all stakeholders that focus on battery technology. The main goal of NBRI is to encourage and support a battery manufacturing industry using local resources, which will enable Indonesia to be independent in energy. The NBRI was supported by the UK Government’s Global Challenge Research Fund (GCRF), part of the Queen Mary University of London QR allocation.About Electric Vehicle Association of Philippines (eVAP)eVAP envisions a nation wherein the use of electric vehicles is highly promoted, encouraged and supported by its government and society to develop a transportation landscape that is one with the environment ecologically and economically. eVAP’s mission is to educate the public on environmental awareness, and the economic and ecological benefits of electric vehicles through the conduct of and/or participation in promotional activities.eVAP aims to accelerate society’s conversion from using gas-powered vehicles to electric vehicles and works with the government in the creation and implementation of legislation that will support and encourage the use of electric vehicles.About NanoMalaysiaNanoMalaysia Berhad was incorporated in 2011 as a company limited by guarantee (CLBG) under the Minister of Science, Technology and Innovation (MOSTI) to act as a business entity entrusted with nanotechnology commercialization activities. Some of its roles include commercialization of nanotechnology research and development, industrialization of nanotechnology, facilitation of investments in nanotechnology and human capital development in nanotechnology. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024 ACN Newswire

Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024

Seoul, Korea, Aug 23, 2024 - (ACN Newswire via SeaPRwire.com) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences advanced technologies industries, has secured three prestigious awards at the esteemed Korea Biopharma Excellence Awards (KBEA) 2024. The KBEA event, held in conjunction with the 13th Annual Biologics Manufacturing Korea & 6th Vaccine World East Asia 2024 on 13-14, August 2024, underscores Avantor’s exceptional achievements in downstream processing and single-use systems, as well as its leadership as a biopharma supplier in Korea.Left: Andrew Wong, Chief Executive Officer/General Manager of Shanghai Wotai Biotechnology, ChinaRight: James Hwang, Head - Biopharma Applications, AMEA, AvantorAvantor received the following awards:Best Bioprocessing Supplier Award: Downstream ProcessingBest Bioprocessing Supplier Award: Single Use SystemsOverall Biopharma Supplier of the YearThese accolades highlight Avantor's commitment to excellence and innovation in bioprocessing. The "Best Bioprocessing Supplier Award: Downstream Processing" acknowledges Avantor's products and solutions that enhance the efficiency and effectiveness of downstream processing in biopharmaceutical manufacturing. Supporting this success is Avantor's Korea Innovation Customer Support Center (ICSC), which serves as a hub of scientific collaboration and innovation. The ICSC team collaborates closely with customers, offering services that help improve yields, reduce production costs, and ensure efficient production.The "Best Bioprocessing Supplier Award: Single Use Systems" recognizes Avantor's pioneering single-use solutions for strengthening production capabilities, streamlining operations, and improve scalability for biopharmaceutical companies. Notably, this marks the fourth consecutive year that Avantor has received the "Best Bioprocessing Supplier Award: Single Use Systems," following wins in 2022, 2021, and 2020.The "Overall Biopharma Supplier of the Year" award is a testament to Avantor's comprehensive impact on the biopharma industry, reflecting the company's dedication to providing high-quality products and services that drive advancements in biopharmaceutical research and production.Jin Young Lee, Head, Biopharma, APAC, Avantor, expressed his gratitude for the recognition, stating, "We are incredibly honoured to receive these prestigious awards at the Korea Biopharma Excellence Awards 2024. These accolades underscore our relentless commitment to innovation and excellence in bioprocessing and reinforces our standing as a premier supplier in the biopharma industry. They are a testament to the hard work and dedication of our team in Korea, who strive to deliver solutions that enable our customers to deliver life-changing therapies to the patients who need them."James Hwang, Head of Biopharma Applications, AMEA, Avantor commented on the awards and said, “Receiving these awards is a testament to our relentless dedication to advancing bioprocessing capabilities. Our commitment to innovation is embodied in the work we do at the Korea Innovation Customer Support Center (ICSC). Our dedicated team of scientists and application experts at the ICSC help customers with process optimisation, troubleshooting, new product proof of concepts, and hands-on trainings to meet their evolving needs. These awards not only recognize our achievements but also highlight the importance of collaboration and customer-centricity in advancing the biopharma industry.”Avantor's recognition at the Korea Biopharma Excellence Awards 2024 follows its recent success at the Asia-Pacific Biopharma Excellence Awards 2024, where the company won five awards, further solidifying its leadership position in the biopharmaceutical industry.About AvantorAvantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visitavantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.Regional Media Contact::Swati ChhabraManager - Corporate Communications, AMEAAvantor91-9958-404-334swati.chhabra@avantorsciences.comGlobal Media Contact:Eric Van ZantenHead - External CommunicationsAvantor1-610-529-6219eric.vanzanten@avantorsciences.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Datacentre & Cloud Infrastructure Summit (DCCI) gears up to transform the Kingdom’s digital future ACN Newswire

Datacentre & Cloud Infrastructure Summit (DCCI) gears up to transform the Kingdom’s digital future

Riyadh, Saudi Arabia, Aug 22, 2024 - (ACN Newswire via SeaPRwire.com) - Having debuted in Saudi Arabia last year, Datacentre & Cloud Infrastructure Summit (DCCI) is pacing for a massive return to the country on 5 – 6 November 2024 at the luxurious JW Marriott Hotel in Riyadh. Poised to gather over 300 industry leaders, experts, and key decision-makers from across the country, the platform will delve into the latest trends, innovations, ground-breaking strategies and give a pulse of the Kingdom’s datacentre & cloud landscape.With global industries expanding their footprint in the Kingdom, cutting-edge events in Riyadh have become a regular phenomenon. In line with VISION 2030, DCCI aims to upgrade the Kingdom’s technology stance by bringing global expertise closer to its datacentre & cloud ecosystem that is pivotal for a diversified economy and paramount to its digital future.To share the latest updates concerning Saudi’s digital infrastructure especially from its datacentres & cloud landscape, DCCI is bringing none other than the top officials from the leading public & private organisations including but not limited to the Ministry of Saudi Arabia National Guard, Saudi Olympic & Paralympic Committee, Saudi Pro League, Saudi Basic Industries Corporation (SABIC), Saudi Entertainment Ventures and Saudi Payments.These officials are not just the leading voices from across sectors but also the embodiment of progress who will be seen taking insightful keynote sessions, engaging fireside chats and deep dive panel discussions on the most pressing topics.Some prominent topics from the summit include, ‘Revolutionizing Saudi Arabia's Digital Infrastructure Landscape’, ‘National Data Sovereignty and Upholding Data Privacy’, ‘A Cloud-Powered Future for a Digital Saudi Arabia’, ‘Reimagining Data Centre Cooling’, ‘Reengineering Data Architecture’, ‘Empowering Next-Generation data centres through AI-Powered Infrastructure’, ‘Sustainable and Green Data Centres for a Digital Saudi Arabia’ and others.Attendees will also get the opportunity to explore the latest datacentre and cloud solutions as the platform will feature a stellar lineup of solution providers including but not limited to Edarat, Legrand Data Center Solutions, Daikin Air Conditioning Saudi Arabia, C&D Technologies, Corning, Hasoub, Austin Hughes, Nlyte Software, Sunbird Software, SETRA, Belden, Rittal, and many more.During the course of two days, DCCI will present an unparalleled opportunity to learn the latest intel, shake hands and network with industry’s very best, have one-on-one interactions with hand-picked profiles and last but not least forge strategic partnerships for growth & development.Organiser and CEO of Tradepass, Sudhir Ranjan Jena stated his organisation’s exemplary vision behind bringing this platform to the Kingdom, “The Datacentre & Cloud Infrastructure Summit (DCCI) is an effort towards powering an era that comes entwined with progress and global collaborations. With a focus on Saudi Arabia’s booming digital infrastructure landscape, DCCI will be a cornerstone for driving the latest datacentre & cloud innovations in the country that’s intrinsic to the Kingdom’s post-oil economy.”About TradepassProviding access to the global emerging markets, Tradepass brings together people, products and solutions to power events for unparalleled business and networking opportunities. Being the most accredited event company, it helps organizations: enter new markets, grow sales pipeline, close prospects, raise capital and identify the right solution-providers.As a deal facilitator, Tradepass is always determined about exposing the most agile liquid growth markets, to enable all-round scalability and growth.For more information about the event, log on to:https://saudi.dccisummit.com/Media contact:Shrinkhal SharadPR & Communication Leadinfo@tradepassglobal.com+ (91) 80 6166 4401Tradepass Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Everest Medicines Announces the Initiation of an Investigator-Initiated Clinical Trial (IIT)

SHANGHAI, Aug 22, 2024 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced the launch of an Investigator-Initiated Clinical Trial (IIT) for a personalized mRNA cancer vaccine, EVM16, under the study EVM16CX01, at the Peking University Cancer Hospital and Fudan University's Cancer Hospital. This trial is designed to assess the safety, tolerability, immunogenicity, and preliminary efficacy of EVM16 injection as a monotherapy and in combination with PD-1 antibody for patients with advanced or recurrent solid tumors. EVM16CX01 is the first-in-human (FIH) trial for EVM16.EVM16 is a novel personalized therapeutic mRNA cancer vaccine independently developed by Everest. EVM16 contains neoantigens with high immunogenicity potential that are predicted based on the unique tumor mutations of each patient by Everest’s proprietary neoantigen prediction algorithm. The vaccine uses a lipid nanoparticle (LNP) delivery system to efficiently deliver neoantigen-encoded mRNA in vivo, activating neoantigen-specific tumor-killing T cells and inhibiting tumor growth."EVM16 is the first personalized mRNA cancer vaccine independently developed by Everest using our proprietary mRNA platform. The initiation of this clinical trial is an important milestone that demonstrates our commitment to discover and develop a new generation of mRNA immunotherapies for cancer and autoimmune diseases.” said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines.“While establishing leadership positions in nephrology, infectious disease, and autoimmune diseases, Everest will also focus on innovative modalities such as therapeutic mRNA vaccines. We look forward to seeing personalized cancer vaccines become a new clinical treatment method to serve more patients."According to the Globocan’s data in 2022, there were 19.976 million new cancer cases globally, with 9.744 million cancer-related deaths1. In the last few decades, Immunotherapy including checkpoint inhibitors has become an important part of treating some cancer types. However, they are only effective for some patients, and there is an urgent need to develop new generations of immunotherapies, such as personalized mRNA cancer vaccines, that have demonstrated early promise in clinical development. In preclinical studies, vaccination with EVM16 stimulated a strong neoantigen-specific T cell response in different mouse models and showed significant tumor growth inhibition in the syngeneic B16F10 mouse melanoma model. Preclinical data also demonstrated that the combination of EVM16 and a PD-1 antibody has synergistic effect, which supports the clinical application of the combination of EVM16 with checkpoint inhibitors. In preclinical toxicity studies, repeated dosing with EVM16 was well tolerated and safe. Taken together, the preclinical immunogenicity, efficacy and safety studies demonstrate that EVM16 is safe and has potential to bring benefits to cancer patients.Everest has built end-to-end capabilities across its proprietary mRNA platform. Our R&D team is developing multiple mRNA-based therapeutic products, as well as next generation lipid nanoparticle (LNP) delivery systems to enhance cell-mediated immune response. Our mRNA manufacturing facility in Jiashan, Zhejiang Province in China is designed to comply with global cGMP standards and is able to produce at clinical- and commercial-scale. Everest owns full global intellectual property rights to its mRNA therapeutic programs.Reference:1.Globocan 2022: https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdfAbout EVM16EVM16 is a novel personalized mRNA cancer vaccine independently developed by Everest Medicines Limited.. EVM16 contains neoantigens with high immunogenicity potential which are predicted by Everest-proprietary algorithm and uses an LNP delivery system to efficiently deliver mRNAs that express tumor neoantigens into the human body. After vaccination with EVM16, neoantigens-encoding mRNAs are delivered into cells to produce neoantigen peptides, which activate neoantigen-specific T cell immune responses to kill tumor cells, thereby inhibiting tumor growthAbout EVM16CX01 studyThe study is a FIH, dose escalation and expansion study to evaluate the safety, tolerability, immunogenicity, and initial efficacy of EVM16 injection as a single and in combination with PD-1 antibody in subjects with advanced or recurrent solid tumors.,. The primary objectives are to evaluate the safety and tolerability of EVM16 monotherapy and EVM16 in combination with PD-1 antibody in subjects with advanced or recurrent solid tumors, and to determine the recommended phase 2 dose (RP2D) of EVM16. The secondary objectives are to evaluate the immunogenicity of EVM16, and the initial efficacy of EVM16 in combination with PD-1 antibody in subjects with advanced or recurrent solid tumors.About Everest MedicinesEverest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company’s core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders.For more information, please visit its website at www.everestmedicines.com.Forward-Looking Statements:This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

云顶新耀宣布自主研发的新型mRNA个性化肿瘤治疗性疫苗正式启动临床试验

上海, 2024年8月22日 - (亚太商讯 via SeaPRwire.com) — 云顶新耀(HKEX 1952.HK)是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司,今日宣布正式启动一款个性化肿瘤疫苗EVM16的研究者发起的临床试验项目(IIT)EVM16CX01。该研究由北京大学肿瘤医院和复旦大学附属肿瘤医院发起,用于评估EVM16注射液单药及联合PD-1抗体治疗在晚期或复发实体瘤受试者的安全性、耐受性、免疫原性和初步疗效的剂量递增及扩展研究。这是EVM16开展的首次人体试验。EVM16是一款云顶新耀自主研发的新型mRNA个性化肿瘤治疗性疫苗,根据每位患者特有的肿瘤细胞突变,使用自主研发的人工智能算法,预测出具有较高免疫原性潜力的新抗原。通过脂质纳米颗粒(LNP)递送系统在体内进行高效的抗原呈递,激活新抗原特异性T细胞,进而达到杀伤肿瘤细胞和治疗癌症的目的。云顶新耀首席执行官罗永庆表示:“EVM16是云顶新耀自主研发的首款个性化mRNA肿瘤疫苗,此次临床试验项目的正式启动意味着公司基于自主知识产权的mRNA平台所开发的肿瘤疫苗产品进入人体试验阶段,有望为肿瘤治疗领域开发出新一代免疫疗法。在构建肾科、感染、自身免疫性疾病领导地位的同时,云顶新耀也快速进入肿瘤治疗性疫苗等创新性治疗领域,开拓新蓝海。我们期待早日看到个性化肿瘤疫苗成为新的临床治疗手段,服务更多患者。”Globocan 2022年统计数据显示,全球新发肿瘤人数1997.6万人,因肿瘤死亡的人数为974.4万人1。以PD-1/PD-L1抑制剂为主的免疫疗法已经成为某些肿瘤治疗非常重要的一部分,但仅对部分患者有效,肿瘤治疗领域急需在此基础上开发新一代免疫疗法。个性化mRNA肿瘤疫苗则成为极具潜力的新一代免疫疗法。在临床前研究中,EVM16在多种小鼠模型中都激发出了强烈的新抗原特异性T细胞免疫反应,在小鼠黑色素瘤B16F10模型中实现了显著的肿瘤生长抑制效果。云顶新耀自研的算法已找到多个已知和之前未报道的肿瘤抗原,并且在多个独立验证研究中的预测表现相当或优于行业领先算法,临床前数据还证明了EVM16疫苗与PD-1抗体联用后的协同抗肿瘤效果,支持个性化肿瘤疫苗与免疫检查点抑制剂在临床中的联用。在临床前安全性评估试验中,EVM16疫苗也展现了良好的安全性。这些结果综合说明,EVM16注射液安全性良好,和免疫检查点抑制剂联用有望给肿瘤患者带来更多临床获益。云顶新耀利用自主知识产权的mRNA平台开发预防及治疗性的mRNA产品,且拥有这些产品的全部知识产权及全部全球权益,并同时具备治疗性mRNA产品全产业链的开发和制造能力。自研团队基于经过临床验证的mRNA技术平台,多路径开发肿瘤及其他治疗药物。目前正在研发多个mRNA肿瘤治疗药物,包括个性化肿瘤疫苗(PCV)、肿瘤相关抗原(TAA)肿瘤疫苗、免疫调节肿瘤疫苗,自体生成CAR-T产品,并开发新一代脂质纳米粒(LNP)递送系统以增强细胞介导的免疫反应。此外,云顶新耀拥有自有商业化规模生产基地,位于浙江嘉善、符合全球良好生产规范(GMP)标准认证的生产基地于2022年12月正式投入运行并成功完成了临床批次生产,为实现mRNA技术平台的本土化研发、生产以及商业化运营奠定坚实的基础。参考文献:1. Globocan 统计数据: https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdf关于EVM16EVM16是一款云顶新耀医药科技有限公司自主研发的新型mRNA个性化肿瘤疫苗。EVM16是用菌种库制备得到的线性化质粒DNA为模板,经体外转录、纯化、除菌过滤制备出mRNA原液,采用脂质纳米颗粒(LNP)技术将mRNA原液包封在由特定脂质组分组成的纳米级脂质颗粒中,加入其他辅料经无菌灌装制成。EVM16根据每位患者独有的肿瘤细胞突变,使用自主研发的人工智能算法,预测出具有较高免疫原性潜力的新抗原,采用脂质纳米颗粒(LNP)递送系统将能高效表达肿瘤新抗原的mRNA递送至人体内。受试者接种EVM16注射液后,mRNA被递送入细胞内生成新抗原肽段,诱导机体产生新抗原特异性的T细胞免疫反应,来杀伤清除表达新抗原的肿瘤细胞而达到抑制肿瘤生长和治疗癌症的目的。关于EVM16CX01研究项目此研究是一项评估EVM16注射液单药及联合PD-1抗体治疗对晚期或复发实体瘤受试者的安全性、耐受性、免疫原性和初步疗效的剂量递增及扩展研究,也是EVM16的首次人体试验。主要研究目的包括评估EVM16单药以及EVM16联合PD-1 抗体在晚期或复发性实体瘤受试者中的安全性和耐受性,确定EVM16的II期推荐剂量(RP2D);次要目的包括评估EVM16在晚期或复发性实体瘤受试者中的免疫原性,以及评估EVM16联合PD-1 抗体在晚期或复发性实体瘤受试者中的初步有效性。关于云顶新耀云顶新耀是一家专注于创新药和疫苗研发、临床开发、制造和商业化的生物制药公司,致力于满足亚洲市场尚未满足的医疗需求。云顶新耀的管理团队在中国及全球领先制药企业从事过高质量研发、临床开发、药政事务、化学制造与控制(CMC)、业务发展和商业化运营,拥有深厚的专长和丰富的经验。云顶新耀已打造多款疾病首创或者同类最佳的药物组合,公司的治疗领域包括肾科疾病、感染性和传染性疾病、自身免疫性疾病。有关更多信息,请访问公司网站: www.everestmedicines.com前瞻性声明本新闻稿所发布的信息中可能会包含某些前瞻性表述,乃基于本公司或管理层在做出表述时对公司业务运营情况及财务状况的现有看法、相信、和现有预期,可能会使用“将”、“预期”、“预测”、“期望”、“打算”、“计划”、“相信”、“预估”、“确信”及其他类似词语进行表述。这些前瞻性表述并非对未来业绩的保证,会受到风险、不确定性及其他因素的影响,有些乃超出本公司的控制范围,难以预计。因此,受我们的业务、竞争环境、政治、经济、法律和社会情况的未来变化及发展等各种因素及假设的影响,实际结果可能会与前瞻性表述所含资料有较大差别。本公司及各附属公司、各位董事、管理人员、顾问及代理未曾且概不承担更新该稿件所载前瞻性表述以反映在本新闻稿发布日后最新信息、未来项目或情形的任何义务,除非法律要求。 Copyright 2024 亚太商讯 via SeaPRwire.com.
More
赛晶科技公布2024年度中期业绩 录得总收入人民币6.56亿元 同比增长43% ACN Newswire

赛晶科技公布2024年度中期业绩 录得总收入人民币6.56亿元 同比增长43%

2024年度中期业绩报告摘要(截至2024年6月30日止6个月)- 总收入为人民币6.56亿元,同比增加约43%;归属母公司净利润3,358万元,同比扭亏为盈。- 配输电业务方面,报告期内集团于该分领域的销售收入达人民币3.58亿元,同比大幅增长105%。其中直流输电业务同比增长177%,柔性输电业务同比增长196%。- 研发方面,将在8月底正式发布自研碳化硅(SiC MOSFET)晶片,电阻率低至13毫欧,达到了国际领先水准。香港, 2024年8月22日 - (亚太商讯 via SeaPRwire.com) — 赛晶科技集团有限公司(「赛晶科技」或「公司」,连同其附属公司统称「集团」;股份代号:0580.HK)披露截至2024年6月30日止半年度(「报告期内」)的业绩公告。报告期内,公司总收入为人民币6.56亿元,较2023年同期增长43%;归属母公司净利润3,358万元,同比扭亏为盈。其中,国内市场收入为人民币6.17亿元,较2023年同期增长40%;国外市场收入为人民币3,871万元,较2023年同期增长94%。 直流输电业务高歌猛进,输配电业务营收同比增长105% 随着直流输电专案数量与市场规模的迅猛扩张,公司依托在直流输电领域稳固的行业领导地位,2024上半年输配电业务营收达到3.58亿元,同比增长105%。其中,在特高压常规直流输电板块,公司圆满交付了服务于“金上-湖北”、“哈密-重庆”、“宁夏-湖南”等国家级特高压工程专案的关键设备订单,推动该领域营收同比增长高达177%。在柔性输电板块,公司主要交付了用于德国BorWin6海上风电柔性直流输电工程及国网四川成都供电公司66KV构网型直挂静止无功发生器(SVG)的订单,实现该领域营收同比增长196%。此外,公司自主研发的柔性直流输电用直流支撑电容器,于2024年初通过国家级新技术产品鉴定,随后在“国网四川成都供电公司66KV构网型直挂静止无功发生器”及“华能玉环2号海上风电专案220千伏送出工程”等多个专案中实现批量供货,并完成了100%的国产替代。有望在后续柔性输电专案中,带来新的业绩增长空间。总体来看,常规直流输电工程、柔性输电工程的在建及储备专案丰富。上半年“金上-湖北”等专案顺利推进,同时“陕北-安徽”等多地储备专案蓄势待发,国外专案如“沙特中西和中南”等也有望开工。此外,“疆电送电川渝”等特高压专案公布,新型输电技术如低频、远海风电直流等不断涌现,拓宽市场空间。直流输电行业快速增长,新技术需求旺盛,公司将凭借领先地位,将持续推动业绩高增长。功率半导体业务客户数量大幅增长,晶片研发成果显著上半年,公司自研功率半导体业务的市场推广和客户开拓工作依然取得了显著成绩。2024年上半年,尽管销售收入受到一定影响,但客户总数实现了同比104%、环比45%的大幅增长。其中,完成测试和供应商导入工作并进入批量供货阶段的客户数量更是同比增长100%、环比增长125%。产能方面,上半年也实现了有序提升。公司已经启动了第三条IGBT模组封装测试生产线,及第一条碳化硅模组封测生产线的厂房内部建设和设备采购工作,有望在2024年底前完成生产调试前的全部准备工作。研发方面,上半年公司自研功率半导体领域取得了显著成果。下半年将有一系列功率半导体晶片推出,进一步丰富了集团的晶片产品线,为公司在高端功率半导体市场的长远发展奠定了坚实基础:- 碳化硅(SiC MOSFET)晶片的研发,电阻率低至【13】毫欧,达到了国际领先水准,将在8月底正式发布。- 采用第七代微沟槽技术的i23系列1200V / 300A IGBT晶片,即将研发完成。同时,采用i23系列晶片的1200V/800A、900A ED封装IGBT模组也将陆续推出。- i20系列IGBT晶片产品线进一步扩展,即1200V / 200A、150A、100A,1700V / 150A、100A、75A等多款晶片研发进展顺利,即将推出。- EP封装IGBT模组,研发进展顺利,即将推出。未来展望为加快构建新型电力系统,促进新能源高质量发展,推动大规模设备更新改造,国家电网公司公布:今年全年电网投资将首次超过6000亿元,比去年新增711亿元。受益于此,特高压常规和柔性直流输电,及海上风电直流送出、构网型SVG、低频输电等柔性输电领域将继续呈现旺盛的市场需求,并有助于提升本集团的业绩表现。公司继续全力加强行销开拓,促进自研功率半导体业务回升及其他各项业务继续增长。- 完 -关于赛晶科技集团有限公司赛晶科技集团有限公司(简称“赛晶科技”),香港主机板上市,股票代码0580.HK。赛晶科技是业内技术领先并深具影响力的电力电子器件供应商和系统集成商,是具备国际领先水准的创新研发型企业,在北京、浙江嘉善、江苏无锡、湖北武汉,以及欧洲的瑞士和德国,拥有十余家子公司。赛晶科技,是港股稀缺的涉及特高压输电、功率半导体、电动汽车、新能源电力行业的上市公司。赛晶科技业务涵盖生产、传输、使用的新能源全产业链,涉及光伏、风电、直流输电、智能电网、电动汽车、轨道交通、电气化船舶、储能及各类工业控制领域。特别是在特高压输电领域,赛晶科技的多款产品长期保持业内技术和市场的领先地位,已经累计参与超过40个特高压、高压输电专案。赛晶科技拥有世界一流的功率半导体研发团队,自研IGBT和SiC晶片及模组获得了电动汽车、新能源发电、储能和工业电控等领域客户的广泛认可。2023年,国内特高压输电专案密集开工,且未来多年的国内、国外市场需求潜力巨大。赛晶科技在特高压领域的行业领先地位稳固、在手订单充足、业务增长确定性极高。此外,2023年赛晶科技功率半导体业务的新产品频出、产能释放加速、市场开拓成果显著,展现出光明而广阔的发展前景。投资者及媒体查询赛晶科技集团有限公司联络人︰吉庆电话:86-10-56301205 / 86-186-11693787电邮:jq@sunking-tech.com Copyright 2024 亚太商讯 via SeaPRwire.com.
More
DreamFolks Expands Footprint to SEAsian Market ACN Newswire

DreamFolks Expands Footprint to SEAsian Market

SINGAPORE, Aug 20, 2024 - (ACN Newswire via SeaPRwire.com) - DreamFolks, India's largest airport services aggregator, is proud to announce its strategic expansion into the Southeast Asian market. This milestone marks a significant step in DreamFolks' mission to redefine travel experiences on a global scale.Over the past 12 years, DreamFolks has revolutionized the airport services industry in India by offering a comprehensive suite of premium services through its proprietary technology platform. The company dominates the Indian domestic lounge access market for debit and credit card programs, boasting an impressive 90% market share and partnerships with most major banks and card networks in the country. The Company went public in September’22 with listings on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).DreamFolks' success stems from its cutting-edge in-house technology, which empowers banks and card networks to significantly enhance their card value propositions. This technology helps boost sales, drives loyalty and optimizes cost for these financial institutions. This tech-driven approach has been key to DreamFolks' success in India and will continue to fuel its expansion into other geographies.The company's global footprint now extends to over 3000 touchpoints across more than 100 countries and 500+ cities, serving millions of travellers annually. This extensive network positions DreamFolks uniquely to offer unparalleled service to its clients and their customers in the new markets.Building on its success in the Indian market, DreamFolks is now poised to bring its innovative service aggregation model to the Southeast Asian market with services like airport and railway lounges, e-SIM: travel SIM cards, meet and assist services, airport transfers, golf privileges and more to their customers.As part of this expansion, DreamFolks has established a regional office in Singapore, demonstrating its commitment to the market. The company has also bolstered its leadership team by on-boarding, Adib Kangda, Senior Vice President – International Markets, a seasoned professional with extensive knowledge of the local market dynamics.Liberatha Kallat, Chairperson and Managing Director of DreamFolks, commented on the expansion and said, "Our expansion into Southeast Asia marks a significant milestone in DreamFolks' journey. We're not just entering new markets; we're bringing our vision of seamless, technology-driven travel experiences to one of the world's most dynamic regions. This area represents immense opportunities for growth and innovation in the travel sector. With our proven track record in India, we're confident that our unique service aggregation model will resonate strongly with banks, card networks and enterprises across the region. By entering the Southeast Asian market, we will introduce market-first card innovations, and significantly save costs for our clients. Our focus is on delivering tangible benefits for our clients, ensuring they experience enhanced value and efficiency."This expansion is expected to benefit both clients and travellers in the region. By offering its advanced technology solutions, DreamFolks aims to help banks, card networks and enterprises optimise their offerings, enhance customer loyalty, and streamline operations. For travellers, this means access to a broader range of premium services and a more seamless travel experience. This expansion not only marks a new chapter in DreamFolks' journey but also promises to elevate the standards of travel services across the region.About DreamFolksDreamFolks is a leading travel & lifestyle services aggregator and provides an in-house technology platform that allows its clients such as Banks, Card Networks, Airlines, OTAs, and Enterprises to create custom offerings for their end consumers. DreamFolks today manages the lounge and other benefits for most of the top Banks in India and enjoys a market share of over 90% in the domestic lounge access market for India-issued debit and credit programs. The company went public in Sep ’22 with listings on both BSE and NSE and has a global footprint extending to 3,000+ touchpoints in 100+ countries, across the world.For more information, please visit our website (www.dreamfolks.com) or contact our media relations team.Contact Information: dreamfolks@adfactorspr.comNamrata Sharma – Namrata.sharma@adfactorspr.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Three Garden Road Achieves WiredScore Platinum Certification ACN Newswire

Three Garden Road Achieves WiredScore Platinum Certification

HONG KONG, Aug 20, 2024 - (ACN Newswire via SeaPRwire.com) - Three Garden Road, a world-class landmark property owned by Champion Real Estate Investment Trust (“Champion REIT” or the “Trust”; stock code: 2778), has achieved the highest level rating of Platinum in WiredScore certification for offices v3.1. This achievement demonstrates its focus on delivering top-tier digital infrastructure and smart building solutions to enhance overall tenant experience.This recognition, along with the Platinum certification of Leadership in Energy and Environmental Design (LEED) “v4.1 Operations and Maintenance: Existing Buildings” attained earlier in 2024, the distinction of being Hong Kong’s first WELL Platinum certification received in 2020 and the BEAM Plus Platinum certification received in 2022, establishes Three Garden Road as Hong Kong’s first “Quadruple Platinum” grade-A office building under the existing building certification category.Three Garden Road is best-in-class across all features of digital connectivity that are essential to tenants, including excellent internet service, wireless network, telecommunications, and power infrastructure:- Seamless mobile and internet experience: unparalleled digital connectivity featuring reliable mobile performance from multiple operators, free Wi-Fi in communal areas to support wellness and community events, and 5G mobile coverage in common areas and car parks- Effortless setup: comprehensive internet setup with multiple high-speed providers, ensuring a perfect fit for tenant needs and a smooth, hassle-free digital experience- Future-ready infrastructure: ample spare capacity throughout the building, including risers, access points, and telecommunications rooms, to accommodate new and emerging technologies and provide tenants with flexibility and adaptability- Resilient systems: robust infrastructure, including multiple points of entry, diverse and secure risers, and telecommunications rooms, effectively mitigating potential interruptions- Smart systems: integration of Internet of Things (IoT) sensors and smart building systems to enhance tenant experience and optimise resource managementMs Christina Hau, Chief Executive Officer of Champion REIT, shared, “Three Garden Road attaining WiredScore Platinum certification speaks volumes about our embrace of intelligent practices and cutting-edge technologies. The property was the first smart building in Hong Kong recognised by the Hong Kong Institute of Architects for its innovative and outstanding architectural design upon its completion. In pursuit of excellence, the Trust maintains a steadfast dedication to integrating smart features into the building’s operational management and facilitating its sustainable development, which is highly valued by our key financial institution and multinational corporation tenants.”Thomasin Crowley, VP of Asia Pacific at WiredScore, said, “Achieving WiredScore Platinum for Three Garden Road is a remarkable accomplishment that underscores Champion REIT’s unwavering dedication to delivering top-tier digital infrastructure in their buildings. This recognition not only testifies the innovative and forward-thinking approach that Champion REIT brings to their real estate assets, but also highlights their commitment to ensuring that their occupiers have access to world-class, reliable, and future-proofed digital amenities that truly sets them apart in today's fast-evolving landscape.”In this July, the Trust held its inaugural ESG Week, featuring a diverse range of impactful activities in collaboration with over 20 partners and organisations. To date, all 100% of its Hong Kong properties have attained the highest Platinum level certification for green buildings, affirming its leadership in implementing sustainable measures. The Trust achieved the top Five-star rating from the Global Real Estate Sustainability Benchmark (GRESB) in 2023.- "Quadruple Platinum" existing building certifications refer to WiredScore certification for offices v3.1 Platinum, Leadership in Energy and Environmental Design (LEED) "v4.1 Operations and Maintenance: Existing Buildings" Platinum, WELL Healthy Building Standard v2 Core Platinum and BEAM Plus Existing Building v2.0 Comprehensive Scheme Final Platinum.– End –Photo caption:Three Garden Road becomes the first-in-Hong-Kong “Quadruple Platinum”existing building.About Champion REIT (2778)Champion Real Estate Investment Trust is a trust formed to own and invest in income- producing office and retail properties. The Trust focuses on Grade-A commercial properties in prime locations. It currently offers investors direct exposure to nearly 3 million sq. ft. of prime office and retail area. These include two Hong Kong landmark properties, Three Garden Road and Langham Place, as well as a joint venture stake in 66 Shoe Lane in Central London. The Trust was awarded the top five-star rating by the Global Real Estate Sustainability Standard (GRESB) in 2023.Website: www.championreit.comMedia Enquiries:Strategic Financial Relations LimitedVicky LeeTel: 2864 4834Email: vicky.lee@sprg.com.hkCynthia NgTel: 2114 4952Email: cynthia.ng@sprg.com.hkTheresa OuyangTel: 2864 4848Email: theresa.ouyang@sprg.com.hkWebsite: www.sprg.com.hk Copyright 2024 ACN Newswire via SeaPRwire.com.
More